ADVERTISEMENT
REVIEW: ‘Like a Rolling Stone’ by Jann Wenner
SHARE
As founder and editor of Rolling Stone magazine, Jann Wenner was chief publicist and mythmaker for the social revolution of the 1960s. So if you choose to read his new memoir Like a Rolling Stone—a question on which I refuse to take sides, you have your own life to live—you might be surprised to discover that there were moments back in those early days when young Jann thought he didn’t really fit in.
He tried to be a rock musician, for example, but he gave it up. The “lifestyle” was too uncertain, too disorderly, he felt. “I liked structure, organization, and leadership.”
Then there was the time Wenner crashed at the pad of Ken Kesey, author of One Flew Over the Cuckoo’s Nest and founder of the troupe of tripping hippies known as the Merry Pranksters. But Kesey’s place was a mess—he had an “open-door policy” for guests and you never knew who the cat might drag in. “My feeling was that I didn’t belong there.” Too yucky.
As a sophomore at UC Berkeley, at the dawn of the Free Speech Movement, Wenner joined a group of radical students that called itself SLATE. But the membership! “A lot of beards, thrift-shop wardrobes, work boots, and bad breath.” Make no mistake: For Jann Wenner bad breath is a deal-breaker, even when the proletariat is trying to wrest control of the means of production. “You are so bourgeois,” his fellow revolutionaries told him.
And the revolutionaries were right (about him being bourgeois, not about the means of production). It’s a fine line Wenner walked, all through the 1960s, ’70s, and ’80s, as a loud advocate for the more enjoyable parts of the ’60s revolution. He was strongly in favor of sexual libertinism, drug legalization, anti-militarism, and the redistribution of everyone’s wealth but his own. He was also in favor of building up a successful publishing business, crushing the competition, acquiring private aircraft, buying many, many houses, filling a warehouse with fancy cars, and amassing a personal fortune in the low-to-mid eight figures.
Before long, Jann Wenner had leapfrogged the bourgeois altogether and become not a radical but a limousine liberal.
The phrase has a quaint feel today, perhaps because the type became so unavoidable. “Limousine liberal” was a term coined back in the ’60s to distinguish a new kind of leftish figure. A limousine liberal wasn’t a committed ideologue like Dorothy Day or Saul Alinsky; nor was he descended from the rank and file of the Democratic Party, those horny handed sons of toil: prairie farmers, union members, ethnic partisans of big city political machines, the sorts of people you might suspect of having bad breath.
Indeed it was a Democratic machine hack from New York who first invented the term as pejorative. His target was John Lindsay, the leftwing mayor of New York City in the late ’60s (and a Republican!). As the father of limousine liberalism, Lindsay counted as his most loyal constituency the wealthy residents of the Upper East Side of Manhattan. They were vocally committed to racial solidarity, economic justice, heavy government regulation, all that jazz—so long as nobody gave their chauffeurs and cooks any fancy ideas.
Over the last 50 years, roughly the lifespan of Rolling Stone, the defection of the white (and now, increasingly, the Hispanic) working class from the Democratic Party left limousine liberals a lot of room for redecoration. They turned the party into a kind of performance space, a stage for striking moral poses and issuing political mandates that always seem to require more from their fellow citizens than from themselves. The well-to-do activists of the Democratic Party, lucky them, get to have their Ben and Jerry’s Groovy Tie Dye Ice Cream Cake and eat it too. The meat-and-potatoes liberalism that shaped the party of Wenner’s youth seems a distant dream. It’s hard to imagine Eleanor Roosevelt posing in a backless number at the Met Gala or George Meany canvassing Martha’s Vineyard for John Kerry’s presidential campaign, as Wenner and his pal Larry David did in 2004.
Politics is not the central theme of Wenner’s memoir, but the evolution of his political identity is one of the things that makes the book interesting. From those early days, when he was made uneasy by the radicals who lived and breathed (ugh) their causes, he has grown into an exemplar of his class and his party. On the very first page of the book he writes: “It was clear that my own story, the saga of Rolling Stone, and the breadth and depth of its horizon could be a great read, and a historically authentic way of telling the story of my generation, our times, and my own mission.” This sentence is an excellent example of the book’s tone: the banal informality (“a great read”) snug against the grandiose (“historically authentic”), wrapped up in preening self-regard (“my own mission”).
It has the additional virtue of being true.
For no one should underestimate the largeness of Jann Wenner’s achievement. Few American magazine editors of the 20th century can match it. Like Harold Ross of the New Yorker, Henry Luce of Time, Life, and Fortune, Clay Felker of New York, and pretty much nobody else, he conceived a hugely successful magazine ex nihilo, to satisfy a public appetite whose potential he alone saw and monetized.
When the first issue of Rolling Stone spun from the presses, in late 1967, popular music was attaining a significance it had never enjoyed before. Thanks to the postwar boom, its teenage audience was flush with cash. The music industry grew in wealth and capacity as the money poured in. Doting on the kids, a small army of eggheads were eager to escape the rigors of traditional liberal arts and treat the kids’ music as a serious artistic and sociological endeavor, regardless of merit.
The most important figure among them was the jazz critic Ralph J. Gleason. Tweedy, elbow-patched, and wreathed in pipe smoke, Gleason saw the potential in the young genius’s idea: Untethered brain power + free-floating cash had to equal something lucrative. Wenner’s plan was to combine gossip, investigative reporting, music criticism, spot news, and narrative features of seemingly infinite length, packaged in a neoclassical graphic design (he banned san serif typefaces from his pages) and touched throughout with knowing humor. The magazine’s self-mocking motto was clipped from the banner of the New York Times: “All the news that fits.” Gleason, a generation older, introduced such un-hippy like conventions as deadlines and budgets to discipline Wenner’s wild inspiration and ferocious energy.
As Wenner tells the story, his success seems a matter of destiny, and I’m willing to believe it. He had a Forrest Gump-like ability to be at the right place at the right time. He was there for the Grateful Dead’s first gig and Kesey’s legendary “acid tests.” He stayed up all night while the Who’s Pete Townshend sketched out his rock opera Tommy for the first time. He sat next to Mick Jagger as Jagger made the final mix of Beggar’s Banquet, perhaps the Rolling Stones’ greatest album. Less than a year after the Beatles’ break-up he got John Lennon to trash his former bandmates in print.
He also had an eye for superior talent and a nose for news. From the start, Rolling Stone owned the most important news stories of the counterculture: the financial fraud of the Monterey Pop Festival, the nightmarish Stones concert at the Altamont raceway, Charles Manson and the Tate-LaBianca murders, the kidnapping of the heiress Patty Hearst, and many more.
A lot of the country’s best journalists were set free to do their finest work for him: P.J. O’Rourke, the travel writer Jan Morris, the critic Lester Bangs, Jon Krakauer, and Hunter S. Thompson, self-appointed founder of “gonzo journalism.” Tom Wolfe was the most celebrated nonfiction writer of the day when Wenner lured him away from Felker’s New York to write a history of the Mercury astronauts. The result was The Right Stuff, which remains a monument to the possibilities of reported prose. Later he let Wolfe move to fiction by serializing his first novel, Bonfire of the Vanities. He took a flyer on the unproved photographer Annie Leibovitz and capped the equally celebrated career of Richard Avedon.
A great editor requires many qualities—an intuitive understanding of his audience, an ability to spot small stirrings before they become big trends, a taste for good writing, money—but self awareness is not one of them. In a memoir as gossipy as Wenner’s this is less of a handicap than you might think. The reader will figure out what’s going on even if the memoirist doesn’t. Wenner seldom lets more than a few pages go by without a reference to his soul-deep friendship with some rock star or other. Bob Dylan drops by when he’s in town. Bruce Springsteen invites him to his horse farm. Jagger jets in for a sail around the Caribbean. Why, a court order couldn’t keep Paul McCartney or Bono or Jackson Browne away from the radiant pleasure of hanging with their pal Jann.
That their pal Jann also just happened to be the editor of their industry’s most important trade magazine—the cover of which generated enough publicity to almost guarantee the success of a new record or tour—is, as Jann himself sees it, an item of no importance in maintaining the spiritual communion he enjoys with these busy, ambitious, calculating, and relentlessly transactional show biz figures. He must be a hoot to be with! His charm, his humor! The sparkle of his conversation! Why else would Bob or Paul or Bruce be so eager for his company? Of course, he usually goes ahead and obliges them with a cover story. What else are friends for?
The same obliviousness holds true in his political excursions. Manmade climate change is evidently unaffected by the long flights on his personal jet. He is, who would’ve guessed, a passionate advocate of gun control and the confiscation of private firearms; one chapter is even titled “Fuck the NRA.” But—boy!—was he ever glad his guide on a cross country motorcycle trip was packing heat to protect him from the rednecks that infest the land between the coasts. (In fairness, I should add that the guide didn’t have to shoot any of them.) He bravely condemned the “greed” unleashed by Ronald Reagan and other Republicans. Yet even as he tends an ever rising pile of money, fighting for every inch of market advantage, squeezing the best financing rates he can from Wall Street, and slashing payroll to juice profits, he never succumbs to greed himself. Greed is one of those terrible character flaws that only afflicts other people. Most of them, thank God, do not have summer compounds in Montauk.
Like most great magazines, Rolling Stone not only fed off its readers’ enthusiasms but in time began to shape them too. In the early days, as the magazine’s and Wenner’s success grew, a debate stirred among the hippies about “whether making money, or more than you needed, was wrong.” Could there be such a thing as “hip capitalism”?
In nearly 600 pages of memoir, Wenner doesn’t answer the question directly—he was never good at making arguments, as he proved in the many pompous, moralizing editorials he wrote for the magazine and insists on quoting here.
His life was his answer—a resounding “Hell yes!” The same market economy he disdained in theory could be squeezed in practice for unlimited financial gain. The radicalism that Wenner flirted with in his youth and quickly rejected requires a kind of self-denial, even asceticism, that couldn’t withstand the constant allurements to which he happily submitted. By contrast, he writes, “I believed in a revolution of culture and consciousness.” Good choice! That kind of revolution is a much lighter lift than a revolution in economic arrangements, and much more fun.
The president that Wenner admires above all others is Bill Clinton, one year Wenner’s junior. Their similarities go beyond their fondness for sexual excess and a tendency to go to pudge if they’re not careful. Like Wenner, Clinton fancied himself a man of the left, with roots in radicalism, but a realist too. Both made a career of taking blistering criticism as sell-outs from leftwing critics whom they inevitably disappointed. Clinton had to disappoint the left because he valued his political success in a center-right nation; Wenner had to disappoint the left because he valued his private plane.
The contradictions and hypocrisies of limousine liberalism could always be obscured in flights of rhetoric. Wenner quotes several of his editorial hymns to Clinton and his vice president Al Gore: “Clinton and Gore are men who came of age in the sixties and whose sensibilities and value systems were formed then. They have … rock and roll in their blood. [Their] election will give our generation the chance to renew our politics and to reconcile our deeply held values with the realities of government.”
Thirty years on Wenner reprints his praise without a trace of irony, much less regret. He fails to mention that Clinton’s administration was notable most of all for passing welfare reform, coddling the bond market, globalizing free trade, hollowing out domestic manufacturing, expanding the inner city drug war, and using mass incarceration as a crime-fighting tactic. All those “deeply held values” made Clinton’s administration easily the most reactionary Democratic government since Grover Cleveland’s. But who’s counting? The limousine rolls on.
Like a Rolling Stone: A Memoir
by Jann Wenner
Little, Brown, 592 pp., $35
Andrew Ferguson is a contributing writer at the Atlantic and nonresident fellow at the American Enterprise Institute.
Published under: Book reviews, Media
2022 All Rights Reserved
Triumph of a Limousine Liberal – Washington Free Beacon
Nigerian oil export terminal had theft line into sea for 9 years – Reuters.com
ABUJA, Oct 6 (Reuters) – Officials in Nigeria discovered an illegal connection line from one of its major oil export terminals into the sea that had been operating undetected for nine years, the head of state oil company NNPC LTD said.
The 4-kilometre (2.5-mile) connection from the Forcados export terminal, which typically exports around 250,000 barrels per day (bpd) of oil, into the sea was found during a clamp-down on theft in the past six weeks, NNPC Chief Executive Mele Kyari told a parliamentary committee late on Tuesday.
"Oil theft in the country has been going on for over 22 years but the dimension and rate it assumed in recent times is unprecedented," Kyari said in an audio recording of the briefing reviewed by Reuters.
Thieves often tap land-based pipelines to siphon oil undetected while they continue to operate, but an illegal line in the ocean is highly unusual and suggests a more sophisticated theft operation.
Forcados operator SPDC, a local subsidiary of Shell (SHEL.L), said the theft pipeline was distant.
"SPDC appreciates the additional surveillance conducted on behalf of NNPC to deal with illegal activities," a spokesperson told Reuters by email.
"However, the recently discovered theft pipeline is approximately 30km away from SPDC’s Forcados terminal. It is not within SPDC’s pipeline right of way."
Nigeria, typically Africa's largest oil exporter, is losing potential revenue from some 600,000 bpd of oil, Kyari said, as some is stolen and as oil companies idle certain fields rather than feed pipelines tapped by thieves.
Crude oil exports fell below 1 million bpd in August for the first time since at least 1990 as a result, starving Nigeria of crucial cash.
Loadings at the terminal have been stopped since a leak was found from a sub-sea hose at the terminal on July 17. Shell said this week that it expected loadings to resume in the second half of October.
In August, NNPC awarded contracts to companies including those owned by former militants to crack down on oil theft.
Our Standards: The Thomson Reuters Trust Principles.
The United States accused Russian mercenaries on Thursday of exploiting natural resources in the Central African Republic, Mali, Sudan and elsewhere to help fund Moscow's war in Ukraine, a charge Russia rejected as "anti-Russian rage."
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2022 Reuters. All rights reserved
Do vegans live longer than meat-eaters? – Livescience.com
Do vegans live longer than meat-eaters? Livescience.com
source
The Court of Master Sommeliers, Americas Presents the First Women’s Sommelier Symposium – wineindustryadvisor.com
A Mentorship Opportunity for Female Sommeliers Hosted by Santa Barbara Vintners Association
SANTA BARBARA COUNTY, Calif. (Oct. 6, 2022) The Court of Master Sommeliers, Americas (CMS-A) has partnered with Santa Barbara Vintners Association, known for its high-end portfolio of wineries and estate vineyards, to present the first Women’s Sommelier Symposium in Santa Barbara County, California. The Women’s Sommelier Symposium, taking place February 19 – 22, 2023, aims to reinforce a new generation of leaders and a legacy strengthened by female representation in key roles within the wine industry.
The Women’s Sommelier Symposium is a two-day mentoring experience for established women in wine to educate, inspire, and build impactful connections with female sommeliers. The Women’s Sommelier Symposium is an essential step toward addressing safety and support for female leaders who are studying to become Master Sommeliers. This symposium will set the stage for future partners and initiatives to join in a movement to shape the wine industry.
Featured speakers include Julia Coney, wine writer, educator, and founder of Black Wine Professionals, several female Master Sommeliers, and local Santa Barbara entrepreneurs. Master Sommelier Emily Wines will be the host and moderator of the symposium in addition to other Master Sommeliers, including Kathryn Morgan, Laura DePasquale, and Virginia Phillip, who will be spearheading a conversation about “turning your side hustle into a business.” The Master Sommeliers will lead sessions on having a seat at the table in career roles often held by men, as well as mentoring the attendees on preparation for the pursuit of the Master Sommelier Diploma.
“I am thrilled to be launching our inaugural event. Supporting gender diversity in our credentials will in turn further female representation in our industry. I look forward to this opportunity to bring the current and future leaders of our profession together for what will be a meaningful weekend of mentorship,” says Emily Wines, Chair of the Court of Master Sommeliers, and featured speaker at the event.
“I joined the organization to make an impact on gender and diversity issues in the hospitality industry,” emphasizes Julie Cohen Theobald, CMS-A Executive Director. “The Women’s Sommelier Symposium is an important step towards our vision of a more inclusive and accessible path for female sommeliers.”
The majority female-owned and led company, Jackson Family Wines, will be the lead presenting sponsor of the event. The family wine business is deeply rooted in female leadership. Chairman and Proprietor Barbara Banke, one of the wine community’s most highly regarded executives and innovators, has spent the last four decades leading the company she co-founded. Today, Jackson Family Wines continues to empower and champion women in the industry by giving women equal voices and opportunities to lead and create impact. In fact, nearly 50 percent of the company’s winemakers are women compared to the national average sitting around 15 percent.
The Women’s Sommelier Symposium is open for those who identify as women to apply if they are accomplished sommeliers through the Court of Master Sommeliers who have passed Certified or Advanced Level and demonstrated significant leadership potential. The application seeks women dedicated to their studies who have barriers to traveling to wine regions to network with other women in the wine industry.
When looking for the location to host the first Women’s Sommelier Symposium and celebrate women in wine, Santa Barbara County was the preeminent choice because it has a higher percentage of female winemakers than most of the world’s wine regions.
The symposium will last from Sunday, February 19, 2023, to Wednesday, February 22, 2023, across the Santa Barbara Wine Country. The application is currently active and will be administered by the SommFoundation.
ABOUT COURT OF MASTER SOMMELIERS, AMERICAS
The Court was established in England in 1977 and sets the global standard of excellence for beverage service within the hospitality industry with integrity, exemplary knowledge, and humility. The first Master Sommelier Diploma Exam to be held in the United States was in 1987. The Americas chapter, which serves both North and South America, was established in 1987. Since then, 182 professionals have earned the title of Master Sommelier as part of the Americas chapter. The title Master Sommelier marks the highest recognition of wine and spirits knowledge, beverage service abilities, and professionalism in the hospitality trade. Education was then, and remains today, the Court’s charter. For more information, please visit www.mastersommeliers.org.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Accessibility Tools
Columbus County Sheriff Jody Greene suspended for racist comments – Carolina Journal
October 6, 2022
There have been loud calls for the removal of Columbus County Sheriff Jody Greene since Sept. 28, when WECT reported on audio recordings of Greene making derogatory comments about black employees. And less than a week later, after the local district attorney, Jon David, filed a motion for him to be removed for the comments, Superior Court Judge Douglas B. Sasser agreed to suspend Green until any decision on removal is finalized.
In the 2019 recordings made by Captain Jason Soles, who is now running against Greene for Columbus County sheriff, Greene can be heard telling Soles, “I’m sick of it. I’m sick of these black bastards” and directing Soles to fire every black employee there to “clean them out” of the office.
Soles served as interim sheriff after Greene narrowly won by 34 votes in 2018 while the election was being litigated. Greene, a Republican, felt that black employees had been helping his Democrat opponent.
“This one particular phone call that [I] received, he made the comment that he hated Democrats. And then he said, ‘I take that back. I hate a black f***ing Democrat,’” Soles told WECT. “And, and I knew right then, I was like, ‘Wow, this is coming from the sheriff.’ And, I had to start recording those conversations… It broke my heart. Because that’s not what I believe in.”
The N.C. Sheriffs Association denounced Greene’s comments, saying, “The North Carolina Sheriffs’ Association (the Association), representing all 100 sheriffs in our state, is aware of racially-charged comments allegedly made by Columbus County Sheriff Jody Greene, that shock the conscience. The comments made on the recording are inflammatory, racially derogatory, insulting, and offensive.”
Greene resigned from the NCSA last week.
A second Raleigh healthcare company executive has pled guilty to defrauding the Medicare system for millions of dollars.
A parent in Chatham County is claiming that a local public school teacher “bullied” his daughter for her Christian faith, telling the child “God isn’t real.” The accusation came during a meeting of the Chatham County School Board Sept 12.
In November’s midterm elections, the stakes are high in the two races for the North Carolina Supreme Court. The high court currently has a 4-3 Democrat majority, so if Republicans flip just one seat, the balance shifts on the court. In a relatively rare opportunity, the four candidates running for the N.C. Supreme Court were…
The N.C. Supreme Court voted 4-3 Tuesday against dropping a group of plaintiffs from the latest stage of the long-running Leandro school funding lawsuit. The ruling was in response to a request filed by attorneys for state lawmakers.
Copyright 2022 John Locke Foundation. All Rights Reserved.
The 10 worst new cars on sale in 2022 – The Car Expert
The 10 worst new cars on sale in 2022 The Car Expert
source
Thousands Attend Grand Opening of Master-Planned Williams Ranch Presented by Williams Homes – businesswire.com
High interest demonstrates homeownership remains the American Dream as the new master-planned Williams Ranch community celebrated its grand opening in the Santa Clarita Valley, CA with more than 3,000 in attendance. (Photo: Business Wire)
High interest demonstrates homeownership remains the American Dream as the new master-planned Williams Ranch community celebrated its grand opening in the Santa Clarita Valley, CA with more than 3,000 in attendance. (Photo: Business Wire)
SANTA CLARITA, Calif.–(BUSINESS WIRE)–Williams Homes celebrated the highly anticipated grand opening of Williams Ranch, welcoming thousands of interested buyers to the Santa Clarita Valley’s newest master-planned community.
Attendance across the opening weekend was estimated at more than 3,000 people. Attendees had the opportunity to tour 15 decorated and landscaped model homes that comprise four residential collections where sales are underway, and demand is strong.
“Interest in Williams Ranch has been building for more than a year, but to see the thousands of visitors who came from near and far for the first look at what we’ve developed here was extremely gratifying,” stated Daniel Faina, Chief Marketing Officer for Williams Homes. “The grand opening attracted people from all over Southern California. We are especially proud of the positive response we received from local residents who came out en masse to support us and see all that Williams Ranch has to offer.”
Williams Ranch presents a selection of seven single-story and eight two-story floorplans set on spacious lots with breathtaking views and some offering RV garages, multi-gen suites or ADUs. Homes range from 1,736 to 4,522 approximate square feet with pricing beginning in the mid $900,000s.
All homes incorporate the latest, advanced technology including Tesla Solar, Ring video doorbell, Honeywell Wi-Fi thermostat, dimmable LED task lighting, tankless water heater, and more.
Residents enjoy a relaxed lifestyle oriented around an exceptional recreation center that will feature a clubhouse, swimming pool, and outdoor kitchen. Surrounded by open space and connected by an intricate trail system, numerous parks, entertainment amphitheater, large citrus orchards, working vineyards, and a wine pavilion; there’s nothing quite like Williams Ranch now selling in the region.
Williams Ranch is located at 28801 Hasley Canyon Road, Castaic, CA. For information, phone 661-344-9200 or visit www.williamsranch.com.
ABOUT WILLIAMS HOMES
Williams Homes is a residential homebuilder headquartered in Los Angeles, California that specializes in building high-quality new homes for families. Founded in 1996, the privately-owned company has built thousands of homes during the last two decades in the Western United States, including communities in California, Montana, Idaho, and Texas. Committed to insightful design and superior craftsmanship, Williams Homes continues to set a new standard in homebuilding and ultimately, the customer experience. For more information, visit www.williamshomes.com.
Media Contact:
Lisa Silagy
Director of Marketing, Williams Homes, Inc.
310.755.8999 | [email protected]
High interest demonstrates homeownership remains the American Dream at Williams Ranch in the Santa Clarita Valley, CA.
Media Contact:
Lisa Silagy
Director of Marketing, Williams Homes, Inc.
310.755.8999 | [email protected]
Album Review – "Ashley McBryde Presents: Lindeville" – savingcountrymusic.com
Reviews 36 Comments
It’s a remarkable achievement that an album like this was even made under the otherwise repressive jurisdiction of the Music Row system in Nashville. No, you should not consider this like a conventional album release by Ashley McBryde, meaning a succession of potential radio singles and album cuts sequenced into a typical track list. McBryde barely appears on some of these songs, and some of the songs aren’t really songs at all. This is more of a conceptualized collaboration between Ashley McBryde and some of her fellow songwriters. It’s also quite interesting, and cool.
The album came together over a week long songwriting retreat at a cabin just outside of Nashville. Such retreats are not uncommon in the mainstream country ecosystem. Eric Church and others take this same tact to making records. They also commonly result in more songs than are needed for an album, and often, songs that are never meant for public consumption, but are written in jest, for the songwriters to entertain each other or stimulate themselves creatively, and sometimes, songs that are just too racy for mass consumption.
Now imagine an album comprised of these other songs that are usually left on the cutting house floor, not because they’re not quality, but because they’re just not songs that are usually considered commercially applicable, at least by prevailing notions. That is what Ashley McBryde Presents: Lindeville is—composed around the characters of a fictional town named after the influential songwriter Dennis Linde, who penned such gems as “Bubba Shot The Jukebox” by Mark Chesnutt, “Goodbye Earl” by the [Dixie] Chicks, and Sammy Kershaw’s “Queen of My Doublewide Trailer,” which incidentally, features the same “Earl” from the “Goodbye Earl” song.
Creating a little universe where the characters from different songs interact with each other is the direct inspiration behind this album. With songs like “Shut Up Sheila” and “Livin’ Next to Leroy,” Ashley McBryde already had a strong penchant for character-driven songs in her repertoire. So with songwriters Aaron Raitiere, Brandy Clark, Caylee Hammack, Connie Harrington, Benjy Davis, Pillbox Patti (Nicolette Hayford), and Brothers Osborne, they chose to create a small town with a specific cast of characters to live in it.
You could consider Lindeville just as much like a stage production as you could a studio album, with the cast of characters unfolding before you as the songs transpire. A few of the tracks are commercials for Lindeville businesses, specifically the “Dandelion Diner,” “Ronnie’s Pawn Shop,” and the “Forken Family Funeral Home,” with Ashley McBryde’s jingles filtered through an AM radio to give them a more authentic feel. For the male characters, Aaron Raiterie, Benjy Davis, and T.J. Osborne step up to sing lead, just as Brandy Clark, Caylee Hammack, and Pillbox Patti do as well. John Osborne of Brothers Osborne was the producer of the album.
Again, not enough can be said about the out-of-the-box nature of this effort, and how unusual this is for a major country music label like Warner Music Nashville to release it. It’s a passion project, and one that couldn’t have been cheap to make. Though Ashley McBryde has been a huge critical success, it’s not like she’s a commercial powerhouse. But somehow she’s won the latitude to make something like this, and you can’t help but cheer her on, even if it’s not your thing. It’s somewhat reminiscent of some Dierks Bentley projects, like Up On The Ridge, or his Hot Country Knights band.
And some of these songs include explicit language, adult themes, and others stuff that typically Nashville major labels would frown upon. But if we’re being honest, this side of the country music songwriting realm also comes with its own set of songwriting clichés. This sort of campy exposé of small town rural life is not novel, including in the mainstream. It’s what Kacey Musgraves started her career on, what the Pistol Annies devoted their first couple of records to, and what has buttered Brandy Clark’s bread for the majority of her career.
You also feel like you need a few more songs here to flesh out a complete picture of the doings of Lindeville. But as the album continues on, the tracks become less silly, and there’s some really stellar and more serious stuff, whether it’s McBryde’s cover of “When Will I Be Loved,” or the inspired “Bonfire At Tina’s” and “Lindeville.” And this album is also unmistakably country—certainly more country than Ashley McBryde’s Jay Joyce-produced studio albums, and definitely more country than what John Osborne and Brothers Osborne are doing these days.
Ashley McBryde has already let it be known that she does have a proper third studio album also on the way, and perhaps sooner than later. Lindeville is just a quick detour on what is increasingly becoming one of the most interesting, critically-acclaimed, and important careers in the mainstream. This is not what she’s expecting to hang the next 18 months of her career on, or to seed radio with singles from.
But Lindeville is one of those albums that will go on to define a more compelling and atypical career from an artist that is helping to break the mold of what we can expect from major label country. Incidentally, it also helps highlight some important songwriters. But perhaps most importantly, Ashley McBryde’s Lindeville symbolizes that we may be entering an era when artists are allowed opportunities to do things that disrupt the regular rhythms of music production instead of only adhering to them. And that is exciting.
Two Guns Up (9/10)
(Editor’s note: In retrospective, the initial score for this record was deemed too low, and was changed.)
– – – – – – – – – –
Purchase Ashley McBryde Presents: Lindeville
Aaron Raitiere, Ashley McBryde, Benjy Davis, Brandy Clark, Brothers Osborne, Caylee Hammack, Connie Harrington, Dennis Linde, Dierks Bentley, Eric Church, Hot Country Knights, John Osborne, Kacey Musgraves, Nicolette Hayford, Pillbox Patti, Pistol Annies, TJ Osborne
Derek Sullivan
September 30, 2022 @ 10:02 am
Ashley is in her creative prime right now. I still go back to listen to Girl Going Nowhere and Never Will and they have stood the test of time. I saw her in concert earlier last month and she played five unreleased tracks and all were amazing. She said during the show that her label won’t release her new album until the spring. Damn, that is too long to wait.
Anne Stearns
September 30, 2022 @ 6:38 pm
You should go listen to Jalopies and Expensive Guitars if you haven’t. It’s just as good!
Kevin Briggs
September 30, 2022 @ 10:10 am
This is truly one of the best albums I have heard in years. Blown away by it on first listen. Have to admire the balls on Ashley to run with this coming off a number 1. This should win every award for country album. Can’t imagine anyone out doing this in the next few years
63Guild
September 30, 2022 @ 11:21 am
I came in with medium expectations on this since it seemed to be a passion project but was blown away, it’s a great album and like Trig pointed out wish therr were a few more songs to round out the little town.
Gabe
September 30, 2022 @ 1:07 pm
Storytelling at its finest.
Johnnyba
September 30, 2022 @ 1:14 pm
I was not a fan but checked it out for the quirky song titles and damn are you right.. Even where it’s musically to much like everything else in mainstream country is substantially strong. And “Gospel Night At the Strip Club” is my favorite song so for this year. It’s like what we might have gotten if John Prine and Tom Waits ever tried to write a song together.
Kevin Briggs
September 30, 2022 @ 1:44 pm
“Does the last call benediction then wipes the bar slate clean” is cherry on top of one of the finest written songs in recent memory
Stellar
October 1, 2022 @ 10:45 pm
I was also reminded of Tom Waits’ weird 1970’s era. Piano has been drinking etc.
KC
September 30, 2022 @ 1:48 pm
As a big Ashley McBryde fan I wasn’t sure what I’d be hearing as I put this album on for a listen last night. I was a tad skeptical but I quickly was enthralled by the drama of this small town. I listened to the album twice through; I laughed, I cried, and I truly reflected on my own life, in my own town.
The song Gospel Night at the Strip Club was incredible, simply as the fact this was released is on a big Nashville label. As a gay member of the country music community, I don’t get to hear much on the perspective of growing up gay in a small town, but those simple words… “Jesus loves the queers” spoke volumes, and Im sure that line hits homes to others who grew up similarly.
By the end of the album I was fully invested in the cast of Lindeville, as they’re all so relatable to many of that characters in our own towns. The final song “Lindeville”, Ashley’s vocals pack a punch. When she goes up an octave on the word whip poor will, I about died, it was so good. The entire album is so good! I imagine it’ll see little airplay on the radio, but no doubt it’ll be loved by the critics, and those who truly love the art form that is storytelling. Well done Ashley and crew. I am impressed by John Osborne’s production here. I hope she drops Joyce and sticks with Osborne. He did a great job.
Stellar
October 1, 2022 @ 10:49 pm
Country music is missing out on an absolute gold mine of every day drama by (mostly) avoiding the topic of small town gays.
also assumed that the homeless main character in the Strip Club song is a gay man, though it’s just implied in the chorus. That song is also one of my favorites released by anyone so far this year.
Ray
September 30, 2022 @ 4:06 pm
She is such an amazing female talent in Nashville. If anyone has ever had the opportunity to Ashley sing live, it is an experience the plays knock knock with your soul. I think her duet with Carly Pearce is one of the best songs that went to radio this year. I want to see Ashley be as appreciated my mainstream fans as much as critics and her die-hard fans.
63Guild
September 30, 2022 @ 4:52 pm
Another thing, Osborne does a great job on production on here and it would be great to see more of this style venture into the Osborne Brothers.
Aggc
September 30, 2022 @ 6:58 pm
I can see this being Album of the Year without even squinting.
Vince Deehan
October 1, 2022 @ 4:23 am
I don’t claim to be an expert on country music, but to my ears this album is an instant classic. The whole album is a joy from start to finish. My favourite song song so far is “Gospel Night At The Strip Club”.
Trey
October 1, 2022 @ 3:37 am
Nice… Dennis Linde…. Burning Love… Elvis. Sold.
Country Charley Crockett’s Butter
October 1, 2022 @ 6:30 am
Mainstream album of the year!!
Honorable Mentions are Lambert, Pardi.
Country Charley Crockett’s Butter
October 1, 2022 @ 6:32 am
Speaking of new albums – im quite intrigued about Trigs thoughts on Kelsea Ballerinis new album…. Cause it’s kinda good & country-ish.
Johnnyb
October 1, 2022 @ 7:46 am
A few observations on the second day listen. I think the key points in the review are that this is a collaboration, particularly with Brandy Clark, and an album where everything fits together in a way that the more pedestrian material is buoyed by its thematic connection to the stronger material. In that, it struck me this morning watching the “Bonfire At Tina’s” video that the project as a whole seems like a snarky, white trash response to “The Highwomen.” (Is that the same Nashville area field the Highwomen used?) I don’t mean that I think they wanted to make fun of it but that they are trying to explore similar and parallel themes in a less pretentious and more humorous manner I think I have a different idea of what the stronger and weaker material is. The sillier stuff seemed stronger than most of the more serious stuff to me. “Brenda Put Your Bra On” is a strong opener that’s reminiscent of “Shotgun Willie” in that it more or less announces what the album is going to be about along with the important fact that it’s not going to take itself too seriously. For me, the first two tracks were quirky, funny, and original enough that when they went to more typically mainstream stuff it didn’t get boring, preachy, or otherwise tedious.
I may change my mind about what’s strongest as I listen more but I doubt that this album would have pulled me in the way it did with a more staid opener.
RyanPD
October 1, 2022 @ 8:35 am
The last sentence of your article needs a colon and just a couple more words: Outlaw shit.
Dave Watkins
October 1, 2022 @ 9:44 am
REALLY enjoyed the whole album, some mighty fine tunes on there.
I just wish there was fewer *bad* words along the way. I know it likely suits the characters and stories but that will severely limit radio airplay. Bonfire At Tina’s has a very strong melody but a simple ‘shit’ near the end messes it up.
Stellar
October 1, 2022 @ 10:51 pm
Radio wouldn’t play most of these anyway, bad words or not
WuK
October 1, 2022 @ 9:51 am
I am a fan of Ashley McBryde and love her previous albums but was not sure I would enjoy this. Read your review and took a chance. Glad I did. Superb. Once of the standout albums of 2022.
Bill
October 1, 2022 @ 12:15 pm
I spent extra time on this one due to the review. Listened to it completely while reading the lyrics on another website, and also Dennis Linde’s Wikipedia entry. I’ve never listened to a complete Ashley McBryde album before. Have to say I was very impressed and really enjoyed it.
Brenda
October 1, 2022 @ 4:07 pm
Never heard of AM until my (and her debut) first time at the opry. Was there with my daughters just reaching adulthood and Girl Goin’ Nowhere blew us away. Nothing better than someone who knows where she is going and plans for it! Enjoyed Lindeville and want more albums like that.
Convict charlie
October 2, 2022 @ 6:41 am
Live and the Opry version no doubt “girl going nowhere” is my favorite song of hers. Via album though “the jacket” is my favorite. I’ve yet to pick this new one up but I will this week. Been my favorite for years for females since I heard “bible and a .44” with Eric church.
Lost Highway
October 2, 2022 @ 10:22 am
I’m not sure if it was her first appearance at the Opry, but did she sing the song Whiskey and Country Music? I saw her sing that on TV last year, and have been looking for a place to buy it ever since. I’m not very familiar with her music, but that song seems like a no brainer to include on an album.
MD
October 1, 2022 @ 10:27 pm
Enjoyed the album, just needed more Ashley Mcbryde. I hope her song interludes on the album have complete versions that will be unearthed someday.
Stellar
October 1, 2022 @ 10:43 pm
I was spending Saturday night helping some friends with a remodel and we were all in separate corners of the house, me in headphones. I put this album on. My friends came running because apparently I started shriekng OH MY GOD!!! and they thought something had happened. No, it’s just an amazing album.
Im a sucker for concept albums but these songs are also just great little vignettes on their own too. The very NSFW first song is hysterical, the Gospel Night At The Strip Club one manages to cram an entire universe into one guy’s experience, the Stars one ties it all together. It’s just glorious. Reminds me of Marty Stuart’s The Pilgrim or any number of early Tom Waits songs in how it paints a picture.
Also, nice nod to the Lindeverse of Queen Of My Double-wide Trailer/Goodbye Earl/Bubba Shot The Jukebox etc.
BJ Barham of American Aquarium did a great interview on Bubba Shot The Podcast, a comedy podcast where they explored 90’s country songs, and in his episode they went deep into the Lindeverse and what American Aquarium learned while making their 90’s covers albums.
Lindeville isn’t set in the same universe as Dennis Linde”s hits, but it has the same kind od cohesiveness as his set od aongs did.
Venturacountryfan
October 2, 2022 @ 4:25 pm
So “Gospel Night” is the consensus favorite here, and it seems to be written and sung by Benjy Davis. I checked out one of his albums and it sounded more adult contemporary. Curious if he had been on Trigger or anyone else’s radar
Trent Dawson
October 5, 2022 @ 6:47 pm
Benjy Davis also produced William Clark Green’s “Hebert Island”.
Dee
October 3, 2022 @ 7:22 am
I’m an Ash fan through and through. I play all five albums (two self released), now six, on a near daily basis; throw in her duets and covers and its a great day.
Lindeville is a fantastic amalgamation of characters and I truly hope these artists come back to visit the town at least once. Maybe twice. And maybe with some new characters, I have several artists I can easily see joining such a project.
As far as songs, The Girl In The Picture and Lindeville are by far my favorite. The commercial jingles give some fun breaks within the album while rounding out the feel of the town. I certainly hope this will give major labels the want to allow artists to start releasing passion projects more often.
Stellar
October 3, 2022 @ 10:06 am
I had to go revisit the story of Livin Next To Leroy after this album. Also a great song.
Dee
October 3, 2022 @ 1:37 pm
Following the character stories on this album was a lot of fun. Caroline’s storyline made me sad for Leroy.
Happy Dan
October 3, 2022 @ 4:46 pm
Damn this is GOOD! Super stoked Aaron Raitiere is all over this, they are a great duet pair.
Gotta say I think it’s better than 8/10
RyanPD
October 7, 2022 @ 7:44 pm
BRA ON, BRA ON
North Woods Country
October 8, 2022 @ 8:03 am
I like the album. It’s fun and there are some great songs on it. It’s also crude and vulgar in both good and bad ways. In some cases, it’s fitting and natural. In other cases, it’s only for the sake of it. “Jesus Jenny” could be cut and this record would add another point for me. I love the jingles–they’re so clever and nostalgic. The Ashley led songs are the highlights for me.
Your email address will not be published. Required fields are marked *
Privacy Policy
↑
The Naya Rockers Announces the Re-Master of Their Hit Album – Grateful Web






The Naya Rockers are back with a remaster of their much-loved 2014 studio album, Naya Sound System. It features plenty of good vibes, irresistible riddims, and star collaborations across its nine tracks. Naya Sound System is due out Oct. 14th and will be available everywhere you stream music. Pre-save and download here: https://ffm.to/nayasoundsystem_pr
Naya Sound System first came about when Nathan Sabanayagam, drummer and one half of the Naya Rockers duo, started traveling to Kingston, Jamaica in 2004. With riddims recorded from his band back in Boston in hand, the idea was to collaborate with other musicians. The seemingly simple idea expanded into a two year journey with home base becoming a rented room in Havendale. After spending several years meeting local artists and becoming familiar with Jamaica’s reggae scene, Nathan put together a short list of stellar artists ready to lend their voices and talents to the album. But by this time the band in Boston was no longer interested in the project thus he needed new riddims. Nathan recalls, “This left me in a tough situation, with many years invested I had to take matters into my own hands. I took the vocals I recorded and produced new riddims to match and out of this remix process was born Naya Sound System Vol. 1 released back in 2014.” He continues, “Almost a decade later, I have remastered the record for release. A dub remix by the Mad Professor of Reggae Train and other versions to follow.”
Naya Sound System is 9 songs deep that catalogs that time in Nathan’s life. “The new release/re-release is a look back for me, a reflective moment where I can revisit my early work and see where I have been,” said Sabanayagam. “As a fan and dedicated student of reggae, I have gone to the source and have been fortunate enough to drink from the well,” he added.
While in Jamacia recording the record Nathan met legendary musicians, worked at legendary venues, record labels, and recording studios. Nathan recalls, “The first track I voiced was Babylon Stress at Tuff Gong during my second trip down.” Among the other legends were the likes of Kiddus I, Mikey General, Frankie Paul, Big Youth, Errol Dunkley, and Johnny Clarke. He worked around the clock recording their voices using a portable rig in hotel rooms, the artists’ homes, and his own makeshift production base in the rented room in Havendale. One frequent haunt was the veranda in the home of guitarist and producer Earl “Chinna” Smith.
“In Jamaica, you record where the music is, and ‘Chinna’s Yard’ has music flowing 24 hours a day,” said Sabanayagam. “This is also where I would eventually be doing most of my production work in Kingston. Having an MBox, ProTools, and a laptop, I was able to capture recordings wherever I was.”
He continues, “Most of the tunes were written on the spot, a chorus would form and we would work from there laying out the arrangement for the verses to fit in between. Lyrics were worked out over the riddim then written on paper or in the case of Frankie Paul who was blind just straight from his head into the mic. We could finish writing the song and recording all vocals including harmonies, lead and adlibs in 3 hours.”
Once he’d recorded all the vocals, Sabanayagam began the arduous task of producing riddims to match. The band on Naya Sound System includes Earl “Chinna” Smith who contributed guitar and some percussion on “Illusions” and “Reggae Train.” Nate Edgar (The Nth Power, John Brown’s Body), the second half of Naya Rockers, on bass.
Nearly a decade later, The Naya Rockers have remastered their iconic record to stunning audio effect. When asked about his process back in Jamaica compared to now, he comments, “As far as gear, I fundamentally stay the same… but have switched my DAW from ProTools and ProTools hardware to Digital Performer and UAD Apollo hardware. The Roland Space Echo is a staple in my production and appears throughout the production as well as a host of plugins, automation and outboard compressors and EQ.” They also added in a few more musicians on the remastered version, including guitar by Van Martin, Mike Keenan and Johnny Trama, keyboards by Zack Brines, and Sabrina Pallini on Backing Vocals for “Don’t give up.” The remastered version was mixed by Nathan Sabanayagam and Will Holland and Chillhouse Studios, and mastered by Jason “Jocko” Randall at More Sound Studios.
Naya Sound System was Nathan’s master class in the business of music. He recalls, “I had to use all the skills I had in order to finish this project and learn a few more. From learning the musical landscape of Kingston to the best way to record vocals in the field. Rebuilding riddims, working with artists, contracts, copyrights, PRO’s at the same time trying to maintain a consistent vision.” He continues, “I always enjoy working and collaborating best. But the nature of this project required that it mostly came from me and it is my interpretation and take of this style and genre. It is what’s in my ears.”
The newly remastered album will see a few remixes, one coming soon with be from the renowned dub artist Mad Professor for “Reggae Train.” And although all the songs are standouts in their own, “Illusions” featuring Kiddus I is a special one for Nathan. He says, “we were recording on the veranda and Just as the track began at the end of Kiddus I’s intro lines a very loud Thunder Clap sounded and Chinna yells “Jah”. Perhaps people may think this is an added effect or overdub but this was truly a mystical occurrence. It was from that moment I would begin working Inna De Yard also eventually, recording and producing a full length LP for Kiddus Green Fa Life.”
In the works is a possible Europe tour with a few of the album collaborators joining Naya Rockers. The live shows will reflect the album as much as possible and even bring in a few dub engineers to help keep the iconic sound of Naya Sound System!
The remastered version of Naya Sound System will be available for streaming and purchase on Oct. 14th, available for pre-save and order here: https://ffm.to/nayasoundsystem. See the full tracklist below:
1. Illusions feat. Kiddus 1
2. Can’t Fool We feat. Mikey General
3. Don’t Give Up feat. Frankie Paul
4. Cast Thy Bread feat. Big Youth
5. My Lady feat. Errol Dunkley
6. Reggae Train feat. Johnny Clarke
7. Babylon Stress feat. Prince Theo
8. Juggling feat. UT Ras
9. Illusions (Dub Version by Mad Professor)
























Be A Part Of The Grateful Web
Contact US
Progressive jam giants Umphrey’s McGee‘s return to Las Vegas for the seventh installment of the massively popular UMBowl production was marked once again by a stand-out tour closing dual evening extravaganza where all stops were pulled out and the power given directly to the fans, for better or for worse.
On June 24, Round Records & ATO Records will release GarciaLive Volume Six: July 5, 1973 – Jerry Garcia & Merl Saunders, the latest installment of the celebrated GarciaLive archival series. The three-CD set was recorded at the 200 capacity Lion’s Share club formerly located in the small town of San Anselmo, CA, just 20 miles north of San Francisco. The performance features Jerry Garcia performing with friend, mentor and legendary keyboardist/vocalist Merl Saunders. The duo is joined by drummer Bill Vitt and bassist John Kahn, who soon became a lifelong Garcia collaborator.
Progressive jam giants Umphrey’s McGee‘s return to Las Vegas for the seventh installment of the massively popular UMBowl production was marked once again by a stand-out tour closing dual evening extravaganza where all stops were pulled out and the power given directly to the fans, for better or for worse.
COPYRIGHT © 1995 – 2022 GRATEFUL WEB, INC. ALL RIGHTS RESERVED.
How To Record Audio on Google Slides – Robots.net
Google Slides is a lifesaver if you’re in a rush to make a presentation. It’s versatile, powerful, and easily accessible so almost anyone with a Google account can use it. However, there is one feature that Google hasn’t implemented: built-in audio and voice recording. Fortunately, you can still insert audio files to make your presentations engaging. You just need to understand how to record audio on Google Slides to make it work. Here’s how.
If you are looking for more programs, here are the best audio editing software today!
Unfortunately, there’s no way you can learn how to audio record on Google Slides directly. Hence, you’ll need to rely on third-party programs to record your voice or audio.
What third-party app can you use to record your Google speech? There are multiple choices you can select from. Some of these include desktop apps like Wondershare DemoCreator (Windows and macOS) or web apps like Online Voice Recorder.
The former is great if you want to know how to record audio on Google Slides on Mac or PC. Meanwhile, the latter is preferable if you’re learning how to record audio on Google Slides on a Chromebook. Regardless, they can both record the audio you need for your Google presentation.
However, remember that each program will work differently so there’s a different learning curve for each. For this example, we’ll use Wondershare DemoCreator to demonstrate how to record your audio file. Follow the directions below for a detailed guide:
If you dislike both Wondershare DemoCreator or Online Voice Recorder, we’ve also included other audio-recording software recommendations further below.
How do you record voice-overs on Slides? While the first option is great for adding simple audio, it’s not ideal for recording live presentations. That’s where this second option of using a plugin comes in.
More specifically, we’re going to recommend a screen recording plugin called Loom. With it, you can learn how to audio record on Google Slides while presenting actual slides. It’s designed for recording live presentations, allowing you to share a video instead of just adding audio to a slide.
Simply install the Loom plugin to begin. Once that’s done, you can start recording yourself and your screen simultaneously. Afterward, you can share the video automatically using a link. With that, you’ve learned how to record audio on Google Slides if you’re aiming to record a live presentation.
Finally, you can also learn how to record audio on Google Slides by using your smartphone’s voice recording app. A majority of modern phones will come with a default voice recording app. However, you can use more robust apps like GarageBand (iOS) or BandLab (Web, Android, and iOS).
With these apps, you can easily record yourself and even add music if you so desire. They’re great for audio recording and are free on the platforms they come in. However, remember that some of these apps only export to certain file types.
For example, BandLab’s smartphone app can only export m4a files. Hence, you’ll have to convert the file to MP3 or WAV for it to run smoothly on Google Slides. Alternatively, you can also use BandLab’s web app if you want more exporting options.
The web app is more versatile and easily accessible. It’s an excellent choice if you’re aiming to learn how to record on Google Slides on a Chromebook. Regardless of which app you use, you should be able to export the file to your computer for Google Slides.
On the other hand, if you’re recording from a mobile device, saving the file is a little trickier. That’s because you’ll have to transfer the file to your computer via a cable first. Alternatively, you may also upload it directly through a cloud service like iCloud or OneDrive.
With that said, we recommend using Google Drive if you want to save time. This is because you will have to save the file to Google Drive anyway. It’s a crucial step when you’re learning how to record audio on Google Slides. Nonetheless, getting the file to your computer is the most important thing after you finish recording.
Learning how to record audio on Google Slides is simple if only one slide requires audio. However, if you want the presentation to play continually with an accompanying narration, you must sync your voice and slides. You may accomplish this by detailing a script that showcases your entire presentation. Make sure to write a script that follows along with the slides and their transitions.
Afterward, you can play the narration and count how many seconds or minutes each slide takes. Then you’ll have to add a timer on each slide to let the whole presentation run without clicking next. Remember to match the timing of each slide to the narration.
With that said, this process is the trickiest part to get right. That’s because getting the timing and visuals right and in sync will require some trial and error. Moreover, you might have to re-record some parts of the narration multiple times if you want to edit anything.
If you want to make things easier, you can also chop the recording into smaller chunks that match each slide. Through this, the viewer can just manually click next once the audio recording and presentation for each slide are over.
Once you’ve exported the file to your computer, we recommend uploading it to Google Drive. Every Google account gets a free allotment of 15 GB of storage. As a result, you should be able to upload your audio file there provided the storage isn’t full.
Simply head to https://drive.google.com to begin. Afterward, click the “New” button and choose “File Upload.” Then simply locate the file you just saved from your audio recording program.
Afterward, you must share the audio file with others before you insert it in your PowerPoint Google presentation. Otherwise, even if you successfully insert the file, others won’t be able to listen to the audio because it’s private.
How do you share the audio recording? Simply right-click on the file within Google Drive after it has finished uploading. Afterward, choose “Share” and select “Anyone with the link can view.” This should allow strangers to at least hear the file as it plays in your presentation.
Finally, the last step of learning how to record audio on Google Slides is inserting the file. Once it has been uploaded and shared, you’ll need to navigate to the specific presentation file you want.
You can do this by looking through your Google Drive folders or heading to https://slides.google.com. Within this link, you should find all your recently created presentations.
You may also make a new file by pressing the plus (+) button on the lower edge of the website. Alternatively, you can also type “slides.new” on a browser to create a new slide.
Afterward, choose the slide where the audio file is supposed to play. Once you’re in the slide, choose “Insert” in the menu bar at the top. Then choose “Audio” and look for the file in your Google Drive. Pick the file you need and press the “Select” button.
Once you’ve inserted the file, a speaker icon should show up within the slide. Simply click it to play the audio. You can also move the audio to any other area within the slide to make it look more presentable.
Most people who learn how to record audio on Google Slides don’t stop at simply inserting the file. That’s because, like most elements of the presentation, you’ll have to make adjustments to get things working just right. This includes everything from the volume to dictating when the audio begins and ends.
Fortunately, the editing process is fairly straightforward. You must only select the audio object (speaker icon) and choose “Format Options” in the menu. Afterward, you should see a variety of settings you can tinker with.
One of the most important adjustments that can make or break your presentation is how loud the audio will be. Thankfully, Google Slides provides a handy volume slider you can adjust to ensure it sounds just right.
Moreover, you can even decide when the audio starts playing. The two options here are “On click” or “Automatically.” If you choose the former, you’ll have to manually click to let the audio start the playback. Meanwhile, the latter option will play the audio automatically once the presentation transitions to the chosen slide.
Furthermore, you can even choose to loop the audio once it finishes. You can also check the “Stop on slide change” option if you want the recording to stop upon changing slides. On the other hand, you can uncheck this option if the audio should play continuously (perfect for long narrations).
Once you’re finished making adjustments, you can also preview the audio by pressing the speaker icon. Then hit the “Play” button to listen and assess how it sounds.
Unfortunately, learning how to record audio on Google Slides requires you to depend on third-party platforms. These can range from mobile apps to full-fledged desktop programs to web-based tools. Fortunately, many apps can assist you when you’re learning how to record audio on Google Slides. We’ve compiled a handful of the best ones you can find on various platforms.
Audacity is a powerful tool that’s free, open-source, and accessible on various platforms. You can use it whether you’re on Windows, Mac, or even Linux. What distinguishes it from the rest is how much you can do with the app.
This is because the app not only lets you record your voice but it also allows you to mix music. You can also easily edit your file, make cuts and loops, and even add effects for better fine-tuning and polishing. Moreover, it’s a decent tool for musicians as you can even record live audio through mixers and digital recording platforms.
Can you record in Google Slides using a mobile app? In the past, we may not have had the technology to do so. However, high-quality recording apps have been abundant in recent years. One of which is BandLab, an audio recording app accessible on the web, Android, and iOS.
It’s one of the best ways you can record audio for Google Slides for free. Simply install the app on your device and you can easily begin. The app’s features and interface are also quite intuitive, so you can start recording in no time.
However, remember that BandLab’s mobile app doesn’t support exporting in multiple file formats. It only supports m4a. Thus, we recommend using the web app for easy exporting. If you insist on using a mobile device, you may also convert the file through a converter.
GarageBand is Apple’s Mac and iOS-only version of BandLab. With it, you can record audio, make music, adjust sounds, make cuts, and more. It’s a versatile tool that’s powerful but slightly lighter than Audacity.
What makes it a good option is how seamless it is to use if you’re within the Apple ecosystem. It’s certainly recommended if you’re learning how to add audio to Google Slides on an iPhone. The app is powerful, intuitive, and free so you can easily begin recording. It probably already exists as a default app on most Apple devices.
Online Voice Recorder is a convenient web-based platform to use if you’re learning how to record audio on Google Drive. You can easily access it from a web browser.
The platform has a built-in microphone so you can record your voice straight away. Moreover, what distinguishes it from alternatives is that it’s free. The website doesn’t ask you to make hidden payments for premium use.
In addition, the app has a handy adjustment tool that lets you tweak your microphone settings. It also automatically detects and cuts out silence at the start and end of every recording. Hence, you can save time on making minor cuts and adjustments post-recording.
How do you record your voice on Google Slides? One of the best ways is by using a reliable desktop application like Wondershare DemoCreator. The app is versatile and intuitive to use, making it great for beginners.
It’s also versatile as it not only has voice recording features but video editing and screen recording capabilities as well. The app is also accessible on both Windows and macOS so nearly anyone can use them. However, you cannot export the files directly to Google Drive. Hence, you must save them to your computer before you can upload them to Google’s storage for inserting into Slides.
Learning how to record audio on Google Slides is necessary if you want to make engaging presentations. This is especially true if you must present something to someone with accompanying narration or instructions.
With it, you can incorporate everything from interviews to music and add a personal touch to your presentation. It’s also a great way to present information without overloading viewers with too many visuals that are better expressed verbally.
Furthermore, learning how to record audio on Google Slides is essential if your main aim is to automate a presentation. This can lift the burden off of the presenter so they don’t have to talk about the same topic twice.
Why Can’t I Insert Audio Into Google Slides?
You cannot insert audio files into Google Slides directly by uploading from your local folder. This is because Google Slides only supports audio files that are linked from Google Drive. Thus, make sure to upload the compatible audio file in Google Drive before you insert it into Google Slides.
What Audio File Types Are Allowed On Google Slides?
Google Slides supports MP3 and WAV files. If your audio file is in those formats, you can safely insert it into Google Slides. However, ensure that you have the proper permissions so you’re not violating any copyrights.
Unfortunately, learning how to record audio on Google Slides isn’t as easy as it is on Microsoft PowerPoint. That’s because you cannot upload files directly to Slides unless they’re uploaded on Google Drive first. Nonetheless, while the feature isn’t exactly perfect, it’s still useful. That’s especially true if you don’t have an Office 365 subscription and can only access Google’s free online suite.
Your email address will not be published. Required fields are marked *
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
Creative Living Ceremony Brings the Band Back Together – The Vineyard Gazette – Martha's Vineyard News
The instruments came marching into the Grange Hall Thursday night: a ukulele, a rusted bugle, two guitars and a clarinet to name just a few.
These were the arsenal of TCD, the 1970’s acoustic outfit reunited on stage in West Tisbury to honor Island musician, producer, chef and friend, Charlie Esposito.
Mr. Esposito is the recipient of the 39th annual Creative Living Award, presented to him at a ceremony Thursday by the Martha’s Vineyard Community Foundation. There, before the band took the stage, friends from various phases of Mr. Esposito’s Island life spoke to honor and thank him for his legacy.
Foundation executive director Emily Bramhall introduced the award, established with a gift from Ruth J. Bogan. The award was created to honor her spirit, Ms. Bramhall said, a spirit which Mr. Esposito embodied with his “broad range of creativity and talent.”
Mr. Esposito moved to the Island at the end of the 1960s playing with his band TCD. After a stint of Menemsha scallop shucking, he became a fixture at the Black Dog Tavern.
“Black Dog in the ‘70s was like the little Ellis Island,” said Lynne Irons, one his many former co-workers in attendance that evening. “Everyone who came to the Island came through there.”
At the Black Dog, Mr. Esposito became famous for Chinese Night, created out of longing for the New York Chinese food he left behind.
“It was hours and hours of eggrolls,” said an emotional Matt Castro, as the scent of Mr. Esposito’s homemade eggrolls wafted through the air.
Ms. Irons summed up the moment: “Charlie, it’s been a long, strange trip.”
Jeremy Berlin, the Island musician who nominated Mr. Esposito for the award, spoke of Mr. Esposito’s days recording and producing Island bands in his studio in the basement of the Educomp building. Mr. Berlin extolled his “incredible reserve of patience” and his ability “to always have a valuable insight.”
Mr. Berlin recalled how one day, when he heard his music on the radio he didn’t even recognize it — a testament, he said, to Mr. Esposito’s production skills.
“He was some kind of wizard with a razor blade, literally cutting the tape,” he said.
Mr. Esposito also mentored Mr. Berlin’s son in music. “He made the Vineyard a great place,” Mr. Berlin said.
The mic then moved to Brooke Ditchfield, who reminisced about their long history together the performing arts. She recalled the first show she directed at the high school, Into the Woods, where Mr. Esposito had rigged up a shadow effect to create the illusion of a giant. It started a pattern, Ms. Ditchfield said, where she would say, “Charlie, I have this crazy idea, do you think we can…?”
“He would always respond with an easy ‘sure,’” she said.
Ms. Ditchfield also talked about the many “life-changing mentorships” he engaged in at the high school, and his pivotal role in creating the Performing Arts Center.
“He encouraged and inspired all those around him,” she said. “He made an immeasurably positive impact.
Accepting the award from foundation co-chair Julie Fay, Mr. Esposito told a few of his own stories: the time he passed an art exam with 20 blank slides on the fly, his accidental angering of Walter Cronkite, and the road trips searching for Sichuan peppercorn for Chinese night. The audience was then given a chance to sample Mr. Esposito’s eggrolls as the band warmed up.
TCD is an acronym for Mr. Timothy Charles Duane, the Island band Mr. Esposito formed with art school buddies Timothy Maxwell and Duane Spencer, the latter of whom traveled up from Nashville for the reunion performance.
A concert by TCD is unpredictable. They played upbeat folks songs including Holy Moly, humorous ballads like Squibnocket, and an a cappella jingle. Later on they performed Holy Moly again but in reverse.
There was no encore that evening — the trio played every song they could remember. And then Mr. Esposito blew out one last note on the clarinet.
Subscribe or become a Friend of the Vineyard Gazette and receive our free newsletters and free and discounted tickets to Gazette events along with our award-winning news and photography.
© 2022 Vineyard Gazette
Nicky Romero reinvents his club sound, debuts new style on "Techtronic" – EDM Sauce
Hi, what are you looking for?
Police Stop Possible Mass Shooting Threat At Bass Canyon
EDMsauce.com Artist of the Week: Pixellay
DISCO FRIES Unveils ‘Friends of Fries’ NFT PACK with RCRDSHP
Griffter rings in the weekend with gritty bass track “All Out” ft. Jones 2.0
AJ Salvatore Crosses Into Rap with “Vitamins” ft. Tokyo’s Revenge
Carl Cox Drops 4 Track EP “Welcome To My World” Ahead Of Album Coming Oct 28th
Nicky Romero reinvents his club sound, debuts new style on “Techtronic”
Scott Rill & Zhiko put their talents together on heartfelt track “Heart In My Hands”
Da Funk Shows Off Newest Single titled, ‘Overcome’
Hotboxx Collabs with Blanco y Negro for a Great Start this Fall with Newest Banger, ‘Azul’
New Music
New Music
Interview New Music
New Music Sponsored Up and Coming
New Music
New Music Sponsored Up and Coming
House Remix
Remix
New Music
Remix
By
Published
Nicky Romero debuts the darker and more club-oriented side of himself with not one but two new releases launching the new club/festival style – “Techtronic” (out now) and “Myriad” (out on October 14) on his imprint Protocol Recordings, celebrating a 10-year anniversary this year. The new sonic direction’s premier track feels fitting perfectly with its name, with deep grooving basslines and a strong kick drum focus; the catchy vocal riff and edgy drop make this one a bonafide killer in the club. “Myriad” follows the same vein but with snares and an overlay of ethereal vocals, creating an upbeat and tribal essence that will have the crowd moving their feet. Romero has already tried and tested both records during the summer festival season to rave reactions, and they’ll be the basis for an EP coming out later this year. From his melodic progressive house days to his underground Monocule alias and now into the new “Techtronic” era under Nicky Romero, he is never one to get complacent.
After taking the world by storm with early hits such as “Legacy” with Krewella and the #1 single “I Could Be The One” with Avicii, Nicky Romero quickly proved that his talent is ever-evolving and here to stay. After launching his Protocol Recordings imprint in 2012, the renowned performer, producer, and label head continued his personal successes with a string of high-profile releases, ranging from collaborations with Armin van Buuren, David Guetta, Dimitri Vegas & Like Mike, W&W, Timmy Trumpet and Steve Aoki to remixes for the likes of Robin Schulz, Kygo, Rita Ora, Steve Aoki, Martin Garrix, Jess Glynne and more. While showcasing his label’s roster via his weekly Protocol Radio show, Nicky Romero continues to innovate and evolve, and with his annual “Nicky Romero & Friends” ADE showcase and the launch of Monocule alter-ego, he keeps proving his ability to turn into gold everything he touches.
Ahead of Carl Cox’s hugely anticipated new album, ‘Electronic Generations’, out October 28th, comes the release of ‘Welcome To My World’ – a hard hitting 4-track…
Global chart-topping artist ACRAZE returns with “Believe” Feat. Goodboys – the DJ/producer’s first official single since his global hit “Do It To It,” which…
Celebrating its 10th anniversary this year, David Jones’ most favored tune “E Samba” now returns in a hot-blooded remix by DJ Kuba & Neitan….
What is going on dance music nation? We are so happy to bring you only the BEST in up and coming music, and today…
Copyright © EDM Sauce
EDM Sauce is reader-supported. We may earn a commission through products purchased using links on this page. Learn more about our process here.
Quantum tunnelling in the context of SARS-CoV-2 infection | Scientific Reports – Nature.com
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
Scientific Reports volume 12, Article number: 16929 (2022)
Metrics details
The SARS-CoV-2 pandemic has added new urgency to the study of viral mechanisms of infection. But while vaccines offer a measure of protection against this specific outbreak, a new era of pandemics has been predicted. In addition to this, COVID-19 has drawn attention to post-viral syndromes and the healthcare burden they entail. It seems integral that knowledge of viral mechanisms is increased through as wide a research field as possible. To this end we propose that quantum biology might offer essential new insights into the problem, especially with regards to the important first step of virus-host invasion. Research in quantum biology often centres around energy or charge transfer. While this is predominantly in the context of photosynthesis there has also been some suggestion that cellular receptors such as olfactory or neural receptors might employ vibration assisted electron tunnelling to augment the lock-and-key mechanism. Quantum tunnelling has also been observed in enzyme function. Enzymes are implicated in the invasion of host cells by the SARS-CoV-2 virus. Receptors such as olfactory receptors also appear to be disrupted by COVID-19. Building on these observations we investigate the evidence that quantum tunnelling might be important in the context of infection with SARS-CoV-2. We illustrate this with a simple model relating the vibronic mode of, for example, a viral spike protein to the likelihood of charge transfer in an idealised receptor. Our results show a distinct parameter regime in which the vibronic mode of the spike protein enhances electron transfer. With this in mind, novel therapeutics to prevent SARS-CoV-2 transmission could potentially be identified by their vibrational spectra.
The SARS-CoV-2 spike protein facilitates host cell invasion by binding with cell membrane embedded ACE2 receptors.
Quantum biology is almost as old as quantum mechanics itself1. Where quantum mechanics is often preoccupied with the interaction of light and matter, photosynthesis, that backbone of biology, is the interaction of light with living matter. Bohr himself delivered a lecture which he titled ‘Light and Life’2. Schrödinger, for his part, wrote What is Life? The Physical Aspect of the Living Cell, which served as inspiration for the discovery of DNA1,3. In a discussion of life, viruses offer a novel case study, straddling, as they do, the properties of both living and non-living systems4. As such, they might also offer a novel application for quantum biology. There has been some research into investigating how quantum mechanics and viruses intersect. For example, Park et al. engineered a virus to obtain enhanced energy transport in excitonic networks5. Quantum dots have been used to label viral proteins in an attempt to enhance live imaging of virus-host interactions6,7. They have also been suggested to have antiviral properties8,9,10. There has even been an attempt to simulate the life cycle of a virus using quantum gates11.
Meanwhile, the new coronavirus SARS-CoV-2 has fundamentally changed the world we find ourselves in. While SARS-CoV-2 vaccine development has been integral, there is some suggestion that we have entered a new era of pandemics12. It seems imperative that research into understanding viral mechanisms is accelerated. One way in which this might be achieved is to look at how research outside of established disciplines might allow new insights into physiological mechanisms. Quantum biology, which looks at how non-trivial quantum effects, such as coherence, tunnelling and entanglement, might play a role in biological systems, is one such field of research13,14,15.
The phenomenon of energy and charge transfer is central to much of the research emerging in this field. There is some evidence that coherent energy and charge transfer play a role in photosynthetic networks13,16,17,18. This is perhaps the best known application of quantum effects in the biological context. Charge transfer, however, is also important in the context of tunnelling in enzymes, which was first observed a number of decades ago19. Electron tunnelling has also been proposed to be the mechanism, or one of the mechanisms, by which olfactants activate olfactory receptors20,21. Olfactory receptors are a class of rhodopsin-like receptors known as G-protein coupled receptors, or GPCRs22,23. These receptors are implicated in numerous important physiological phenomena from the regulation of inflammation to the binding of neurotransmitters, the latter of which is currently emerging as a new application of vibration-assisted electron tunnelling24,25,26. Electron tunnelling in these contexts has been investigated as an alternative to the lock-and-key mechanism, a shape-based explanation of receptor binding.
Our primary motivation in this paper is the following: given the importance of receptor recognition, binding and activation in the biological context and given the expansion of the lock-and-key model to include the possibility of vibration-assisted tunnelling, it is salient to review the evidence for tunnelling in the context of viral mechanisms of host invasion. This paper follows two main threads. First we outline the case for quantum tunnelling as an alternative or augmentation to the lock-and-key mechanism in the context of enzyme function, olfaction and neurotransmitter reception. We then review those aspects of SARS-CoV-2 infection that suggest a role for quantum tunnelling, specifically the involvement of enzymes as well as certain types of receptors. We also address the possible consequences of this connection using three aspects of SARS-CoV-2 infection: host cell invasion, medical intervention and post-viral syndrome.
While quantum coherence in photosynthesis might garner more attention, quantum tunnelling in a biological context is arguably the oldest exemplar of the field of quantum biology. In the 1960s, Löwdin suggested that proton tunnelling might be the physical basis of DNA mutations1,27 an idea that is still very much of interest today28. Also in the 1960s, enzymes, first described over a century ago by Fischer as operating through a lock-and-key mechanism29, were subsequently suggested to exploit quantum tunnelling1,19,27. Both electron and proton tunnelling in enzymes is now a well established field of research30,31,32,33. Other biological phenomena have also been characterised as utilising the lock-and-key mechanism of receptor binding. Cellular receptors bind with specific ligands and are integral to signalling processes throughout the body34. Receptor recognition and binding accounts for a range of physiological phenomena35.
An important class of these receptors are G-protein coupled receptors (GPCRs), examples of which are receptors that mediate the sense of smell or the binding of neurotransmitters in order to open ion channels. What is interesting about GPCRs, in the context of quantum biology, is that they are related to rhodopsin22,23. Rhodopsin is a retinal photoreceptor protein which consists of the light-sensitive chromophore retinal in an opsin protein36. Chromophores are a central theme with respect to quantum effects in photosynthesis, where it has been suggested that quantum coherence might play a role in energy and charge transfer16,17,18. This is perhaps less a unique feature of photosynthesis than it is due to the more general arrangement of chromophores in a protein37. Chromophores, then, would appear to be important to redox activity in biological materials. There is also a growing focus on the role that the protein scaffold might play in enhancing energy or charge transfer. Far from the warm, wet, decoherent environment that is often cited as an argument against quantum effects in biology, the vibrational or spin states of proteins might be coupled to electronic states in a favourable way38,39. Interaction with proteins can fundamentally change the properties of a chromophore. Rhodopsin and related opsins, for instance, absorb across a range of frequencies even though they share the same chromophore: retinal. What differs is the opsin protein, which tunes the chromophore’s absorption frequency40.
The coupling of vibrational to electronic states is most often imagined with respect to the proteins in which the chromophore is embedded, but it might be re-imagined in terms of protein-receptor bonding. While it is still debatable that GPCRs, being related to rhodopsins, operate through a mechanism related to electron transfer, both olfaction and neurotransmitter binding have been of interest in the context of quantum biology. Olfaction has conventionally been described as operating through the recognisable shapes of olfactants21. However, this model has to some extent failed at fully describing the intricacies of our olfactory apparatus. This has given rise to an alternative vibrational theory of olfaction. In this theory, the vibrational spectrum of a ligand rather than its shape is responsible for receptor activation by facilitating electron tunnelling20,41. While there is some evidence to support the differentiation of deuterated odorants in various species24,42,43,44, there remains some scepticism with regards to the theory45. The suggestion has been made that the mechanism of olfaction might be closer to a swipe card model, with various different factors contributing46.
More recently, attempts have been made to apply the vibrational theory of olfaction in a different physiological context: the binding of neurotransmitters. Neurotransmitters are integral to the process of neural signal transmission. Signals travelling along the axon of a nerve cell are communicated to adjacent nerve cells by the release of neurotransmitters across the synaptic cleft between cells47. These neurotransmitters bind to membrane receptors which facilitate the opening of ion channels and thus initiate the activation of nerve cells47. Theoretical research suggests that the action of specific neurotransmitters such as serotonin and related ligands is correlated to their vibrational spectra24,48. Similar theoretical effects have been suggested for the binding of histamine26 and adenosine25,49 although experimental verification is still lacking. What we would like to highlight, however, is the fact that charge transfer is a well established topic in quantum biology. More specifically, the biological context of this transfer is very often that of membrane-embedded proteins. Within this research much attention is paid to how the biological environment might assist transfer processes, through, for example the vibrations of the protein scaffold or the vibrations of a binding ligand. It is thus potentially informative to consider this in the context of infection by the SARS-CoV-2 virus, which utilises membrane-embedded proteins to invade host cells, see Fig. 1.
Our current knowledge of the SARS-CoV-2 virus touches on a number of the specific biological instances outlined in our discussion of tunnelling effects: enzymes, receptor binding and olfaction. Before it can proliferate, the virus first needs to invade its host cell. Research suggests that the SARS-CoV-2 virus most likely invades host cells by interaction with host enzymes, in particular angiotensin converting enzyme (ACE2)50,51. The spike protein of the virus, which is also the target of the vaccine, binds with membrane-embedded ACE2 and facilitates the fusion of virus and host membrane52,53. In its ordinary cellular context, ACE2 is an enzyme that modulates the form of the GPCR-binding ligand angiotensin, a hormone that is part of the renin-angiotensin-aldosterone system (RAAS). Among other things, angiotensin is important to the balance of vasodilation and vasoconstriction and is integral to cardiovascular function54,55,56. The exact interaction of the coronavirus spike protein with its host cell is also of potential importance in light of the new mutated versions of the virus57,58. Mutations in the viral genome that code for the spike protein have led to fears of increased transmissability59,60. While the ACE2 enzyme is currently the focus of much of the research, other enzymes have also been implicated in SARS-CoV-2 viral infection. Research suggests that the host cell enzyme serine protease TMPRSS2 is necessary for protein priming of the spike protein and facilitates the virus entering the host cell61,62. Another enzyme, cathepsin L, has been linked to spike protein cleavage and enhanced viral entry into host cells61,63. Given the importance of enzymes in viral activity and given the fact that quantum tunnelling plays a role in enzyme activity it seems a closer look at quantum effects in the context of viruses might prove fruitful.
More generally, a closer look at receptor mechanisms might offer some insights. Criticism of the vibration assisted tunnelling theory of olfaction often points to the fact that there isn’t evidence for electron transfer in olfactory receptors, which are GPCRs64. However, a recent, as yet to be reviewed, paper suggests that there is the potential for electron transfer in certain types of GPCRs. Various possibilities for the specific site of this electron transfer are explored in detail in the paper64. In the context of SARS-CoV-2, one of these is of particular interest: the disulfide bridge. ACE2 is not a G-protein coupled receptor. Evidence does suggest, however, that its interaction with the spike protein might involve redox activity65,66,67. This redox status is also suggested to involve a disulfide bridge. Both spike protein and ACE2 are rich in cysteine residues, which are implicated in intramolecular disulfide bonds65. Indeed, the infectivity of SARS-CoV-2 appears to depend on the disulfide redox potential with resistant animals lacking a redox-active disulfide65,66. Binding affinity has also been demonstrated to be significantly impaired when the disulfide bonds of ACE2 and SARS-CoV-2 spike proteins are reduced67. ACE2 receptors have a disulfide bridge in common with certain types of GPCRs. While we acknowledge that this is far from definitive, we think there is enough evidence to at least inspire some interest in the possibility of electron transfer in receptors in general and in COVID infection in particular. We think this for the following reasons. Firstly, the identification of the disulfide bridge in GPCRs, which is also found in the ACE-2 receptor that we model. Secondly, electron transfer through proteins is well established in quantum biology, as is the fact that this transfer is aided by protein vibrations. It is thus not completely unfounded to consider that electron transfer might play a role in the proteins that constitute receptors, especially given the presence of cysteine and tyrosine sites, which have been implicated in electron transfer reactions in other contexts.
GPCRs themselves also appear to play a role in the disease associated with SARS-CoV-2 infection. The effects of COVID-19 on olfaction have been widely documented as one of the defining symptoms of the disease68,69. ACE2 has elevated expression in the olfactory epithelium, where olfactory GPCRs are also located, which might account for the anosmia or altered sense of smell associated with COVID-1970. GPCRs are also important in the context of COVID-19 inflammatory responses. Increased morbidity has been linked to the cytokine storm induced by the virus. Cytokines are small proteins produced by immune cells. The overproduction and dysregulation of cytokines, however, may lead to tissue damage and death71,72,73. As such, cytokines have been suggested as a possible therapeutic target to ameliorate COVID-19 mortality71,72. A specific class of cytokines known as chemokines, and the chemokine receptor system, have been implicated in the severe clinical sequelae of COVID-1974. Chemokine receptors belong to a group of rhodopsin-like transmembrane GPCRs similar to those activated by neurotransmitters and odorants23,75. Whether or not quantum effects might be at play in any of these facets of SARS-CoV-2 infection and COVID-19 is debatable. However, molecular recognition and binding in the physiological context is integral to viral infection. As a common factor to enzyme function, receptor binding, olfactory symptoms and immune response, it deserves closer scrutiny through as many lenses as possible.
A schematic illustrating the concept of an open quantum system, including the Hamiltonians (H) that mathematically describe the system and environment as well as the interaction between the two. Biological systems interact with their environments and thus are often modelled using an open systems approach. This involves modelling the system and environment as a closed system, the environment is then traced out to arrive at the reduced system dynamics.
A simplified illustration of vibration assisted tunnelling in the context of SARS-CoV-2 infection. The spike protein vibrational spectrum matches the energy of transition for an electron in the ACE2 receptor, facilitating electron transfer and the activation of the receptor.
We model the interaction of the spike protein and the ACE2 receptor as a vibration assisted electron transfer39,76. Biological systems interact with their environments and thus are often modelled using an open systems approach. In this approach the ligand protein, the receptor and environment are considered a closed system before tracing out the environment to get the reduced dynamics of the system of interest. See Fig. 2 for a simple illustration of the concept of an open quantum system, including the Hamiltonians ((H_S) and (H_E)) that mathematically describe the system and environment as well as the interaction ((H_I)) between the two. The Hamiltonian describing the system, environment and their interaction is used to derive the master equation77. Using this open systems approach and borrowing from a model developed for olfaction78, we outline here the relationship between the maximum transfer probability in an ACE2 receptor and its coupling to a single vibronic mode associated with a SARS-CoV-2 spike protein. To simplify things we model the receptor as a dimer (see Fig. 3) where the Hamiltonian is given by:
where (varepsilon _D) and (varepsilon _A) are the energy levels of the donor (D) and acceptor (A) levels and J describes the coupling between levels and the likelihood of transition. For a dimer isolated from external interaction, the maximum probability of a transition from donor to acceptor is given by
where (Delta =(varepsilon _A-varepsilon _D)/2). When the energy of the donor and the acceptor are equal then the probability of transfer ([P_{Drightarrow A}(t_0)]=1) at time (t_0=pi /2J)76. For a dimer that is not isolated the total Hamiltonian is given by:
The receptor is represented by the dimer with Hamiltonian, (H_R). The Hamiltonian of the ligand, in this case the spike protein, is represented as a harmonic oscillator with frequencies (omega) associated with the protein:
The interaction between the receptor and the protein is given by:
The sum runs over the interaction of the protein with both the donor and the acceptor; the latter is presumed to be zero in the numerical solution. The coupling strength between ligand protein and receptor is given by (gamma) and a and (a^{dagger }) are the creation and annihilation operators associated with the spike protein vibrations, with associated frequency (omega). The Hamiltonians (H_R), (H_P) and (H_{R-P}) represent the system in our model of SARS-CoV-2 receptor tunnelling. The membrane environment (H_E) and its interaction with the receptor (H_{R-E}) are similarly approximated as:
and:
where (gamma _{iE}) represents the coupling between the receptor and its membrane environment. This coupling is taken to be weaker than the spike protein coupling to the receptor. The Hamiltonians (H_{R-P}) and (H_{R-E}) represent competing interactions, (H_{R-P}) is essential for receptor recognition of the spike protein, (H_{R-E}) on the other hand describes undifferentiated coupling to a multitude of environmental vibronic modes in the vicinity of the receptor. The spike protein vibrations are discriminated from the environment vibrations through their specific frequencies as well as the stronger coupling constants78. Here the sum runs over both the donor and the acceptor as well as all the possible environmental vibrations.
We now employ an open systems approach. The total density matrix of the receptor, protein and membrane environment satisfy Liouville’s equation:
where H denotes the total Hamiltonian describing the spike protein, receptor and membrane environment (Eq. 3). Here we are interested in the reduced dynamics of the protein and receptor only. This can be achieved by tracing out the membrane environment degrees of freedom, namely
If we assume a weak coupling between the receptor and the membrane environment, we can apply the Born–Markov approximation and replace Liouville’s equation for the total system (Eq. 8) by the corresponding master equation for the reduced system (for receptor and protein only) as follows77:
where (H_{R-E}(t)) denotes the interaction Hamiltonian between receptor and membrane environment in the interacting picture and is given by,
To calculate the sum over the environmental degrees of freedom we introduce the spectral density as,
After integrating over the environmental degrees of freedom and time (tau) we obtain the following master equation,
where (kappa _j=pi (J_j(0-)+J_j(0+))) denotes respective coupling of donor and acceptor to the membrane environment. We assume that the initial state of the dimer (receptor) is at the donor site, and the vibronic mode is initially in the thermal state (T = 300 K). Using numerical simulation, we would like to understand if coupling to a vibronic mode could enhance the transition probability in the dimer system: from donor to acceptor. To this end, we will measure the usefulness of the vibronic mode coupling by considering the following difference:
where (text {Max}[P_{Drightarrow A}(t)]_{text {vibronic mode}}) denotes the maximum probability of the transition in the dimer system calculated from the numerical integration of Eq. (6), while (text {Max}[P_{Drightarrow A}(t)]) represents the maximum probability of transition without vibronic mode coupling, given by Eq. (2).
The difference (text {Max}[P_{Drightarrow A}(t)]_{text {vibronic mode}}- text {Max}[P_{Drightarrow A}(t)]) is plotted for a range of parameters. These parameters have been estimated with respect to comparable biological contexts, in particular Solov’yov et al.’s model for vibration-assisted tunnelling in olfactory receptors78. For clarity we have collected these parameters in Table 1. The coupling between spike protein and receptor ((gamma)) is plotted from weak to strong coupling and we have assumed that the coupling only occurs between the spike protein and the donor level, that is (gamma _A=0). This coupling strength is plotted as a fraction of the vibronic frequency and hence is unitless. Average energy levels and level coupling are estimated with respect to redox processes in other biological systems78,80. This coupling between levels in the dimer (J) is then plotted for a range of different values for each vibronic frequency: 0.0001, 0.001, 0.01 and 0.1 eV. The frequencies of the vibronic mode of the spike protein are taken from studies that investigate SARS-CoV-2 using Raman spectroscopy79. This includes the vibrational spectrum for both the S1 and S2 subunits as well as the full spike protein and the receptor binding domain79. We have plotted results for three different frequencies (omega _1 = 0.2069) eV ((1669 ; text {cm}^{-1})), (omega _2 = 0.1537) eV ((1240 ; text {cm}^{-1})) and (omega _3 = 0.1240) eV ((1000 ; text {cm}^{-1})), see Figs. 4, 5 and 6. For closer reference, we have taken the specific peaks corresponding to the spike protein Amide I, Amide III and phenylalanine, see Supplementary Table S1 in Ref.79 for details. All three cases show a parameter regime in which the vibronic mode enhances electron transfer probability. White regions represent parameter regions where vibronic modes do not enhance electron transfer probability. Redder regions are where vibronic modes have a negative effect on electron transfer probability. Bluer regions represent where vibronic modes enhance electron transfer probability. Vibronic modes have a marked effect on transfer probability in a selective parameter regime, with this effect growing as coupling strength between levels increases. However when coupling between dimer levels is too weak (J = 0.0001 eV) the vibronic mode has no effect. And when the coupling is too strong (J = 0.1 eV) the vibronic mode begins to have a negative effect. This suggests a distinct biologically relevant parameter window in which vibration-assisted tunnelling takes place. Although the different frequencies of the vibronic mode display similar effects, the higher frequency (see Fig. 4) appears to only have a single parameter regime in which the vibronic mode shows marked enhancement. However, lower frequencies (see Figs. 5 and 6) appear to have two regimes in which the vibronic mode enhances transfer probability. Whereas Figs. 4, 5 and 6 demonstrate the effects of the proposed model over a range of biologically viable parameters, we were also interested in testing the model at the extremes of these parameters. To this end we have chosen the dimer coupling strength with the least favourable outcome (J = 0.1 eV) and plotted the effects of the vibronic coupling ((gamma _D)) for very strong coupling to the vibronic mode. While this has an unfavourable effect at small dimer detuning, at larger dimer detuning the effect becomes favourable, showing enhanced transfer probability in distinct regions, especially for higher frequencies of the vibronic mode (see Fig. 7). In our simple model we have used only some of the peaks of the spike protein spectrum. However, we suspect that all vibrational modes of the spike protein will have some effect on electron transfer over the biologically relevant parameter range that we have chosen, either enhancing (blue regions) or decreasing (red regions) transfer, as we have shown on the graphs. We wanted to illustrate this as simply as possible, even though the real transfer may rely on the cumulative effects of all vibrational modes. This is why we have plotted the graphs over parameter ranges rather than for exact parameters, which are lacking. Our approach demonstrates which parameters are favoured for which vibrational frequencies. It would be interesting, given more accurate parameters for dimer coupling strength and protein-receptor coupling strength, to check whether these exact parameters correspond to enhancement at the strong vibrational modes. For now our model is an idealised one which we nonetheless hope serves as a useful overview of the concept.
The difference between the maximum probability of transition with and without vibronic mode (Delta P_{text {Max}}) as a function of the dimer detuning ((varepsilon _A-varepsilon _D)) and the coupling strength between donor and vibronic mode ((gamma _D)). Results show coupling to vibronic mode frequency (omega = 0.2069) eV ((1669 ; text {cm}^{-1})). Bluer regions show enhanced transfer with vibronic modes, white regions show no enhancement while redder regions demonstrate decreased transfer. Graphs (a)–(d) show the effects of increasing dimer coupling strength by an order of magnitude from J = 0.0001 eV to J = 0.1 eV. The results effectively illustrate the window of (biologically relevant) parameters within which vibration-assisted tunnelling has an effect.
The difference between the maximum probability of transition with and without vibronic mode (Delta P_{text {Max}}) as a function of the dimer detuning ((varepsilon _A-varepsilon _D)) and the coupling strength between donor and vibronic mode ((gamma _D)). Results show coupling to vibronic mode frequency (omega = 0.1537) eV ((1240 ; text {cm}^{-1})). Bluer regions show enhanced transfer with vibronic modes, white regions show no enhancement while redder regions demonstrate decreased transfer. Graphs (a)–(d) show the effects of increasing dimer coupling strength by an order of magnitude from J = 0.0001 eV to J = 0.1 eV. The results effectively illustrate the window of (biologically relevant) parameters within which vibration-assisted tunnelling has an effect.
The difference between the maximum probability of transition with and without vibronic mode (Delta P_{text {Max}}) as a function of the dimer detuning ((varepsilon _A-varepsilon _D)) and the coupling strength between donor and vibronic mode ((gamma _D)). Results show coupling to vibronic mode frequency (omega = 0.1240) eV ((1000 ; text {cm}^{-1})). Bluer regions show enhanced transfer with vibronic modes, white regions show no enhancement while redder regions demonstrate decreased transfer. Graphs (a)–(d) show the effects of increasing dimer coupling strength by an order of magnitude from J = 0.0001 eV to J = 0.1 eV. The results effectively illustrate the window of (biologically relevant) parameters within which vibration-assisted tunnelling has an effect.
The difference between the maximum probability of transition with and without vibronic mode (Delta P_{text {Max}}) as a function of the dimer detuning ((varepsilon _A-varepsilon _D)) and the coupling strength between donor and vibronic mode ((gamma _D)). Comparison of highest and lowest vibronic frequencies (omega = 0.2069) eV ((1669 ; text {cm}^{-1})) and (omega = 0.1240) eV ((1000 ; text {cm}^{-1})) for very strong coupling to vibronic mode. Coupling strength with respect to frequency is plotted up to a maximum of 2 rather than 1, as in previous figures. The detuning between the dimer levels is plotted up to 0.5 eV rather than 0.2 eV as in previous figures.
A better understanding of the various ways in which viruses and host cells interact through molecular recognition and binding might also lead to novel treatments for COVID-19. It has already been suggested that treatment with ACE2 inhibitors might have an effect on the severity of the disease. However, reviews are mixed as to whether this treatment may help or harm81,82. It has also been suggested that introducing soluble ACE2 might work against the virus by binding to the viral spike protein before it can bind to membrane ACE2 receptors83. ACE2 receptors also catalyse the different forms of angiotensin that bind with GPC receptors, in particular angiotensin receptors54,55. Whereas ACE2 inhibitors prevent the production of different angiotensin proteins, angiotensin receptor blockers prevent the action of angiotensin proteins. What is interesting is that there is some evidence that targeting angiotensin receptors with receptor blockers also confers some protection against the SARS-CoV-2 virus84,85,86.
Mechanisms of receptor binding are an important factor in pharmaceutical development. GPCRs, for instance, are one of the major targets of many pharmaceutical drugs and bind to a broad spectrum of ligands87. The specificity of this binding is complicated by receptor promiscuity and related antagonism or partial agonism88. Does the spike protein’s affinity for ACE2 receptors also mean an affinity or partial agony for related angiotensin receptors, and GPCRs more generally? The involvement of GPCRs in viral infection has already been investigated in the context of the Ebola and Marburg viruses which employ a glycoprotein to facilitate host invasion. Chemical screening allowed for the indentification of a number of inhibitory agonists of various GPCRs, including receptors for serotonin, histamine, and acetylcholine, which showed antiviral action89. The SARS-CoV-2 spike protein is also a glycoprotein and screening for appropriate GPCR agonists might also yield novel therapeutic options. Tryptophans, for instance, have been demonstrated to play a potentially therapeutic role in SARS-CoV-2 infection90,91. Tryptophan is the precursor to serotonin, perhaps most widely known as a neurotransmitter implicated in mental illnesses such as depression92. In the field of quantum biology there has been recent interest in whether quantum effects play a role in the binding of serotonin to its relevant GPCRs24,48.
What makes this more interesting in the context of COVID-19 is that antidepressants known as selective serotonin reuptake inhibitors (SSRIs) have been shown to be somewhat effective against the SARS-CoV-2 virus93,94,95. While the studies are far from being conclusive this isn’t the first time that these antidepressants have been investigated as antivirals, although the mechanism of action appears to be less to do with serotonin modulation than viral replication96,97. Recent studies also suggest that SSRIs are not alone in their potential as a COVID-19 therapeutic. Other antidepressants, including venlafaxine, appear to improve the prognosis of patients hospitalised with COVID-1994. Venlafaxine targets both serotonin and norepinephrine, both of which bind to GPCRs to activate ion channels98,99.
Other GPCR agonists have also been reported to have some effect in mitigating COVID-19 infection. Histamine, which plays a role in neuromodulation and transmission in addition to mediating immune and allergy responses, is an agonist that binds to a number of GPCRs100. Antihistamines, on the other hand, bind to histamine GPCRs and act as blockers or reverse agonists. There is some evidence that certain antihistamines protect against SARS-CoV-2 infection by disrupting the way in which the virus binds to its host cell101. There is still some doubt as to whether nicotinic receptors act, as least in part, as GPCRs102. These receptors, which bind the neurotransmitter acetylcholine as well as the agonist nicotine, do however open ion channels103,104. Whereas there is little debate that smoking itself offers any protection against COVID-19, surprising statistics around the hospitalisation of smokers and non-smokers with COVID-19 has led to some speculation that nicotine might be a potentially therapeutic intervention against severe disease. It remains unclear, however, whether the effects of nicotine are helpful or harmful105,106.
The generalisation of the vibrational theory of olfaction to the binding of neurotransmitters has led to some suggestion that the agonist and antagonist action of certain ligands might be classified according to their vibrational spectra25,26,49. In the context of SARS-CoV-2, new therapeutics might be discovered by screening and selecting related ligands through, for example, their Raman spectra. The different vibrational spectra of mutated spike proteins might also allow some prediction of the infectivity of new variants of SARS-CoV-2. This paper has focused on the SARS-CoV-2 spike protein binding to ACE2 receptors and its possible interaction with G-protein coupled receptors. In particular it has looked at at how the spike protein vibronic mode might alter electron transfer in certain receptors. What many of these receptors potentially have in common is a disulfide bridge and the potential for redox activity64,65. Targeting the disulfide bonds has been shown to modulate host cell invasion66. This interest in the redox activity of the SARS-CoV-2 virus might also be extended beyond host cell invasion to offer insights on other aspects of COVID-19. ACE2 is a regulator of oxidative stress and it has been suggested that increased vulnerability to COVID-19 is related to increased oxidative stress, through factors such as increased age or underlying health issues65,107,108,109. Redox reactions proliferate in the body, not least in the electron transport chains within mitochondria. The spike protein has also been shown to directly modulate mitochondrial activity, most probably through ACE2 signalling110. Whether or not the spike protein is involved, a growing body of research suggests that mitochondria are implicated in COVID-19 and as such might inform novel therapeutic options107,111,112.
.
While redox considerations, receptor binding mechanisms and the involvement of GPCRs in SARS-CoV-2 infection might lead to possible novel treatments for the disease, it might also offer insights into the post-viral condition referred to as ‘long COVID’113. Research into this condition is still in the very early stages, and much of it is focused on the urgent need for more research to be undertaken, due to the large number of people who appear to experience long term symptoms relating to COVID-19113,114,115. Long COVID is not necessarily correlated with the severity of the active infection, with some patients reporting mild symptoms during the initial, acute stage of the disease before going on to experience lingering sequelae113,116. Some of the long-term effects may be due to damage wrought by COVID-19 to organs such as the lungs and heart116,117,118. However, an appreciable portion of those reporting long term effects show no obvious biomarkers to account for their disorienting collection of symptoms, ranging from fatigue and joint pain to brain fog, memory problems, mood swings and mental illness116,117.
In its lack of defining mechanism and broad range of symptoms, long COVID resembles the condition that is sometimes called myalgic encephalomyelitis (ME) or chronic fatigue syndrome (CFS)113,117. It is well known that viral infections can cause a range of long term effects119,120. Despite this, the condition remains under-researched, and, due to its various psychological manifestations often prompts suggestions that the syndrome is psychosomatic121,122. There is some research, however, that points to the involvement of GPCRs in both ME and CFS, in particular the disruption of GPCR function by autoantibodies123,124,125. GPC receptors control a wide range of essential functions and bind to a broad spectrum of different ligands, which makes them an excellent target for drug development. However this also means that specific ligands might interact with receptors other than their primary receptor, contributing, for example, to the side-effects of a GPCR-targeting drug87. Whether long COVID involves GPCR disruption remains to be seen. But if ACE2 can bind both the SARS-CoV-2 virus as well as molecules such as angiotensin, then perhaps the virus can mimic, at least partially, the way in which angiotensin binds to GPCRs, either through specific viral proteins or through autoantibodies.
GPCR disruption would also potentially explain the wide-ranging array of symptoms reported by long COVID sufferers, as GPCRs are implicated in many different physiological processes22. GPCR involvement in ion channel action might also prove an avenue of research for potential therapeutics. Viruses or the virome play an important, as yet not fully understood, role in the body126. It is thus conceivable that long COVID is a manifestation of some aspect of the SARS-CoV-2 virus being incorporated into host cells even beyond the infected stage. Viroporins, for instance are viral proteins that can oligomerise in host cell membranes to form ion channels of their own127,128. The physiological mechanisms behind both ME and CFS have been suggested to involve ion channels129. It might thus be interesting to investigate this in the context of long COVID, particularly as the envelope protein found in the SARS-CoV-2 virus has been shown to have viroporin capabilities130,131. Ion channels are instrumental in maintaining membrane potential. While it is more common knowledge that membrane potential is integral to the activation and efficient function of nerve cells, all cells have an associated membrane potential. It is also becoming clearer that this membrane potential plays an important role in disease, not least cancer132,133.
Membrane potential is also integral to mitochondrial function, where it is coupled to energy and charge transfer in metabolic processes. Both ME and CFS have been suggested to involve metabolic processes134,135. It has recently been suggested that long COVID resembles ME and CFS in redox imbalance, inflammation, an impaired ability to generate adenosine triphosphate (ATP), and general hypometabolic state, all of which implicate mitochondria in the process107,112. There is some evidence that supporting redox processes, through co-enzymes for instance, may help with metabolic illnesses136,137. There is even some evidence that the ingestion of chlorophyll, the chromophore central to photosynthesis, might alter mitochondrial ATP production138. It is thus perhaps not too much of a stretch to suggest that elements of the SARS-CoV-2 virus might be incorporated into the redox function of mitochondria. These issues are periphery to our main purpose in this paper, which is to model the binding of the SARS-CoV-2 spike protein as an electron transfer process. However, we hope that the discussion might lead to the consideration of other contexts in which protein binding might disrupt the electronic properties of cells and how this might inform both novel treatments as well as post-viral long-term symptoms.
This paper has been structured around two related assertions. The first of these builds on the possibility that the lock-and-key or shape-based mechanism used to describe a number of biological phenomena might be replaced or augmented by a quantum tunnelling mechanism. As such, quantum tunnelling is worth investigating in a variety of contexts where molecular recognition and reception play a role; in particular, in this paper, in the context of membrane-receptor binding of SARS-CoV-2. The second assertion addresses this specific context and the way in which quantum tunnelling might be implicated in the receptor binding of the SARS-CoV-2 spike protein, either through the role of enzymes or the involvement of GPCRs. In the event of the latter, the degeneracy that no doubt allows biological systems their flexibility, also allows for the wide range of symptoms attributed to COVID-19 and long COVID. If GPCR-targeting pharmaceuticals can target more than the specific receptor they are aimed at, causing a variety of side-effects, then perhaps the spike protein behaves in a similar manner. And perhaps a better understanding of receptor recognition might contribute to better medical intervention. Regardless of whether these assertions prove to be true, the point remains that questions of interest in quantum biology, such as tunnelling in the context of enzymes and GPC receptors, intersect with some of the open questions in SARS-CoV-2 research. As such, quantum biology can add to the store of knowledge that will offer protection against the SARS-CoV-2 virus as well as novel future viruses.
Techniques used in quantum biology, such as the comparison of vibrational spectra to predict GPCR agonist potency24, might also inform approaches to virus research. The vibrational characteristics of the SARS-CoV-2 spike protein have already been used to gain insight into its structure by translating the protein into music139. More prosaically, SARS-CoV-2 infection has also been investigated using Raman spectroscopy140,141. This might be extended to comparing the spectra of mutated spike proteins and whether this correlates with how infectious the mutated versions are, in a manner similar to how the potency of serotonin receptor ligands might be classified by vibrational spectra24,142. Vibrational spectra might also be used to identify new drugs to protect against infection. Vibration-assisted tunnelling in the context of neurotransmitters has already inspired research into the use of vibrational spectra to classify different ligands that bind to specific receptors25,26. This could be generalised to the case of SARS-CoV-2 infection using the appropriate vibrational spectra. One example of this is the use of soluble ACE-2, or angiotensin blockers, to protect against SARS-CoV-281,82. If vibrational frequency is implicated in this binding, then pharmaceuticals with similar vibrational frequencies to these treatments could be investigated for their potential protective effects.
Quantum biology might also offer some insights into the long term debilitating effects of COVID-19 and shape possible treatments. While the focus in this paper has been on quantum tunnelling in enzymes and GPC receptors, other related mechanisms of interest in quantum biology offer further avenues of research. ACE2, for example, is a regulator of oxidative stress65. Reactive oxygen species (ROS) have also been implicated in GPCR activity143. ROS are important signalling molecules but are also implicated in cellular inflammation and damage144. The production of ROS has been demonstrated to be sensitive to magnetic fields, a fact that has been attributed to the involvement of radical pairs, one of the primary topics of interest in quantum biology145. Inflammation is a contributing factor in both acute infection with the SARS-CoV-2 virus as well as in long COVID146,147. Recently it has been shown that the application of electromagnetic fields can significantly ameliorate the inflammation associated with COVID-19148. Progress made in quantum biology may thus have even more to offer the study of viruses than the preliminary ideas laid out in this paper.
Not Applicable. The authors did not use data sets, only parameters from appropriately referenced papers in the public domain.
McFadden, J. & Al-Khalili, J. The origins of quantum biology. Proc. R. Soc. A. 474, 20180674 (2018).
ADS MathSciNet PubMed PubMed Central MATH Google Scholar
Bohr, N. Light and life. Nature 131, 421–423 (1933).
ADS MATH Google Scholar
Schrödinger, E. What is life? London (Cambridge University Press, Cambridge***, 1944).
Google Scholar
Hegde, N. R., Maddur, M. S., Kaveri, S. V. & Bayry, J. Reasons to include viruses in the tree of life. Nat. Rev. Microbiol. 7, 615 (2009).
CAS PubMed Google Scholar
Park, H. et al. Enhanced energy transport in genetically engineered excitonic networks. Nat. Mater. 15(2), 211–6 (2016).
ADS CAS PubMed Google Scholar
Yamauchi, Y. Quantum dots crack the influenza uncoating puzzle. PNAS 116(7), 2404–2406 (2019).
ADS CAS PubMed PubMed Central Google Scholar
Qin, C. et al. Real-time dissection of dynamic uncoating of individual influenza viruses. Proc. Natl. Acad. Sci. 116, 2577–2582 (2019).
ADS CAS PubMed PubMed Central Google Scholar
Loczecin, A. et al. Functional carbon quantum dots as medical countermeasures to human coronavirus. ACS Appl. Mater. Interfaces. 11(46), 42964–42974 (2019).
Google Scholar
Manivannan, S. et al. Quantum dots as a promising agent to combat COVID-19. Appl. Organomet. Chem. 34, e5887 (2020).
CAS PubMed PubMed Central Google Scholar
Kotta, S. et al. Exploring the potential of carbon dots to combat COVID-19. Front. Mol. Biosci. 7, 616575 (2020).
CAS PubMed PubMed Central Google Scholar
Shojaie, F. & Dehestani, M. The simulation of virus life cycle with quantum gates. Comput. Biol. Med. 40(3), 359–362 (2010).
CAS PubMed Google Scholar
Peters, M. A. The coming pandemic era. In Educational Philosophy and Theory (Routledge, 2020).
Marais, A. et al. The future of quantum biology. J. R. Soc. Interface 15, 20180640 (2018).
PubMed PubMed Central Google Scholar
Al-Khalili, J. & McFadden, J. Life on the edge: The coming of age of quantum biology (UK Bantam Press, London***, 2014).
Google Scholar
Mohseni, M. et al. (eds) Quantum Effects in Biology (UK Cambridge University Press, Cambridge***, 2013).
Google Scholar
Engel, G. S. et al. Evidence for wavelike energy transfer through quantum coherence in photosynthetic systems. Nature 446, 782 (2007).
ADS CAS PubMed Google Scholar
Brixner, T. et al. Two-dimensional spectroscopy of electronic couplings in photosynthesis. Nature 434, 625 (2005).
ADS CAS PubMed Google Scholar
van Grondelle, R. & Novoderezhkin, V. I. Quantum effects in photosynthesis. Proc. Chem. 3, 198 (2011).
Google Scholar
DeVault, D. & Chance, B. Studies of photosynthesis using a pulsed laser: I. Temperature dependence of cytochrome oxidation rate in chromatium. Evidence for tunneling. Biophys. J . 6, 825–847 (1966).
CAS PubMed Google Scholar
Horsfield, A. P., Haase, A. & Turin, L. Molecular recognition in olfaction. Adv. Phys. X 2(3), 937 (2017).
CAS Google Scholar
Reese, A., Holmgaard List, N., Kongsted, J. & Solov‘yov, I. A. How far does a receptor influence vibrational properties of an odorant?. PLoS One 11(3), e0152345 (2016).
PubMed PubMed Central Google Scholar
Rosenbaum, D. M., Rasmussen, S. G. F. & Kobilka, B. K. The structure and function of G-protein-coupled receptors. Nature 459(7245), 356–363 (2009).
ADS CAS PubMed PubMed Central Google Scholar
Gehrckens, A., Horsfield, A., Skoulakis, E. & Turin, L. Gated electron transport in rhodopsin and its relevance to GPCR activation. preprint on biorxiv. https://doi.org/10.1101/650531 (2019).
Hoehn, R. D., Nichols, D., Neven, H. & Kais, S. Neuroreceptor activation by vibration-assisted tunneling. Sci. Rep. 5, 9990 (2015).
ADS CAS PubMed PubMed Central Google Scholar
Chee, H. K. & Oh, S. J. Molecular vibration-activity relationship in the agonism of adenosine receptors. Genom. Inform. 11(4), 282 (2013).
Google Scholar
Oh, S. J. Characteristics in molecular vibrational frequency patterns between agonists and antagonists of histamine receptors. Genom. Inform. 10(2), 128 (2012).
Google Scholar
Löwdin, P. Proton tunneling in DNA and its biological implications. Rev. Mod. Phys. 35, 724 (1963).
ADS Google Scholar
Slocombe, L., Al-Khalili, J. S. & Sacchi, M. Quantum and classical effects in DNA point mutations: Watson–Crick tautomerism in AT and GC base pairs. Phys. Chem. Chem. Phys. 23, 4141–4150 (2021).
CAS PubMed Google Scholar
Fischer, E. Ber. Dtsch. Chem. Ges.27, 2985 (1894).
Sutcliffe, M. J. & Scrutton, N. S. Enzymology takes a quantum leap forward. Philos. Trans. A Math. Phys. Eng. Sci. 358(1766), 367–386 (2000).
ADS CAS PubMed Google Scholar
Pusuluk, O. et al. Proton tunnelling in hydrogen bonds and its implications in an induced-fit model of enzyme catalysis. Proc. R. Soc. A. 474, 20180037 (2018).
ADS MathSciNet PubMed Central MATH Google Scholar
Bothma, J. P. et al. The role of quantum effects in proton transfer reactions in enzymes: Quantum tunneling in a noisy environment?. New J. Phys. 12, 055002 (2010).
ADS Google Scholar
Moser, C. et al. Guidelines for tunneling in enzymes. Biochim. Biophys. Acta BBA Bioenerget. 1797(9), 1573–1586 (2010).
CAS Google Scholar
Tripathi, A., & Bankaitis, V. A. Molecular docking: From lock and key to combination lock. J. Mol. Med. Clin. Appl. https://doi.org/10.16966/2575-0305.106 (2017).
Uings, I. J. & Farrow, S. N. Cell receptors and cell signalling. Mol. Pathol. MP 53(6), 295–299. https://doi.org/10.1136/mp.53.6.295 (2000).
CAS Article PubMed Google Scholar
Filipek, S., Stenkamp, R. E., Teller, D. C. & Palczewski, K. G protein-coupled receptor rhodopsin: A prospectus. Annu. Rev. Physiol. 65, 851–879 (2003).
CAS PubMed Google Scholar
Toole, J. T., Kurian, P. & Craddock, T. J. A. J. Cogn. Sci. 19, 115 (2018).
Google Scholar
Abramavicius, D. & Valkunas, L. Role of coherent vibrations in energy transfer and conversion in photosynthetic pigment-protein complexes. Photosynth. Res. 127(1), 33–47 (2016).
CAS PubMed Google Scholar
Marais, A., Sinayskiy, I., Kay, A., Petruccione, F. & Ekert, A. Decoherence-assisted transport in quantum networks. New J. Phys. 15, 013038 (2013).
ADS MathSciNet CAS Google Scholar
Wang, W., Geiger, J. H. & Borhan, B. The photochemical determinants of color vision: Revealing how opsins tune their chromophore’s absorption wavelength. BioEssays 36(1), 65–74 (2014).
CAS PubMed Google Scholar
Maniati, K. et al. Vibrational detection of odorant functional groups by Drosophila melanogaster. eNeuro4(5), (2017).
Franco, M. I., Turin, L., Mershin, A. & Skoulakis, E. M. Molecular vibration-sensing component in Drosophila melanogaster olfaction. Proc. Natl. Acad. Sci. U. S. A. 108(9), 3797 (2011).
ADS CAS PubMed PubMed Central Google Scholar
Hara, J. Olfactory discrimination between glycine and deuterated glycine by fish. Experientia 33(5), 618 (1977).
CAS PubMed Google Scholar
Havens, B. R. & Melone, C. D. The application of deuterated sex pheromone mimics of the American cockroach (Periplaneta americana, L.), to the study of Wright’s vibrational theory of olfaction. Dev. Food Sci. 37, 497 (1995).
Google Scholar
Block, E. et al. Implausibility of the vibrational theory of olfaction. PNAS 112(21), E2766–E2774 (2015).
CAS PubMed PubMed Central Google Scholar
Brookes, J. C., Horsfield, A. P. & Stoneham, A. M. The swipe card model of odorant recognition. Sensors (Basel) 12(11), 15709–49 (2012).
ADS CAS Google Scholar
Lodish, H. et al. Molecular Cell Biology 4th edn. (W.H. Freeman, New York***, 2000).
Google Scholar
Hoehn, R. D., Nichols, D. E., McCorvy, J. D., Neven, H. & Kais, S. Experimental evaluation of the generalized vibrational theory of G protein-coupled receptor activation. PNAS 114(22), 5595 (2017).
ADS CAS PubMed PubMed Central Google Scholar
Chee, H. K., Yang, J., Joung, J., Zhang, B. & Oh, S. J. Characteristic molecular vibrations of adenosine receptor ligands. FEBS Lett. 589(4), 548 (2015).
CAS PubMed Google Scholar
Ni, W. et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care 24(422), 1–10 (2020).
Google Scholar
Bhalla, V., Blish, C. A. & South, A. M. A historical perspective on ACE2 in the COVID-19 era. J. Hum. Hypertens. 35, 935–9 (2020).
PubMed PubMed Central Google Scholar
Tang, T., Bidon, M., Jaimes, J. A., Whittaker, G. R. & Daniel, S. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antiviral Res. 178, 104792 (2020).
CAS PubMed PubMed Central Google Scholar
Malik, J. A. et al. Targets and strategies for vaccine development against SARS-CoV-2. Biomed. Pharmacother. 137, 111254 (2021).
CAS PubMed PubMed Central Google Scholar
Tikellis, C. & Thomas, M. C. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int. J. Pept. (2012).
Burrell, L. M., Johnston, C. I., Tikellis, C. & Cooper, M. E. ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol. Metab. 15(4), 166–9 (2004).
CAS PubMed PubMed Central Google Scholar
Gheblawi, M. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin–angiotensin system. Circ. Res. 126, 1456–1474 (2020).
CAS PubMed Google Scholar
Tegally, H. et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature 592, 438–443 (2021).
ADS CAS PubMed Google Scholar
Tao, K. et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet. 22, 757–73 (2021).
CAS PubMed PubMed Central Google Scholar
Volz, E. et al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell 184(1), 64–75 (2021).
CAS PubMed PubMed Central Google Scholar
Zhang, L. et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat. Commun. 11, 6013 (2020).
ADS CAS PubMed PubMed Central Google Scholar
Seth, S., Batra, J. & Srinivasan, S. COVID-19: Targeting proteases in viral invasion and host immune response. Front. Mol. Biosci. 7, 215 (2020).
CAS PubMed PubMed Central Google Scholar
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2), 271–280 (2020).
CAS PubMed PubMed Central Google Scholar
Gomes, C. P. et al. Cathepsin L in COVID-19: From pharmacological evidences to genetics. Front. Cell. Infect. Microbiol. 10, 589505 (2020).
PubMed PubMed Central Google Scholar
Gehrckens, A. S., Horsfield, A. P., Skoulakis, E. M. C & Turin, L. Evidence for free radical drug ligands in class A G-protein coupled receptors. bioRxiv 2021.08.30.458164.
Singh, J., Dhindsa, R. S., Misra, V. & Singh, B. SARS-CoV2 infectivity is potentially modulated by host redox status. Comput. Struct. Biotechnol. J. 18, 3705–3711 (2020).
CAS PubMed PubMed Central Google Scholar
Manček-Keber, M. et al. Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs. FASEB J. 35: 6, e21651 (2021).
Google Scholar
Hati, S. & Bhattacharyya, S. Impact of thiol-disulfide balance on the binding of Covid-19 spike protein with angiotensin-converting enzyme 2 receptor. ACS Omega 5(26), 16292–16298 (2020).
CAS PubMed PubMed Central Google Scholar
Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur. Arch. Otorhinolaryngol. 277, 2251–2261 (2020).
PubMed PubMed Central Google Scholar
Sedaghat, A. R., Gengler, I. & Speth, M. M. Olfactory dysfunction: A highly prevalent symptom of COVID-19 with public health significance. Otolaryngol. Head Neck Surg. 163(1), 12–15 (2020).
PubMed Google Scholar
Chen, M. et al. Elevated ACE2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Eur. Respir. J. 53(3), 2001948 (2020).
Google Scholar
Ragab, R., Eldin, H. S., Taeimah, M., Khattab, R. & Salem, R. The COVID-19 cytokine storm. What we know so far. Front. Immunol. 11, 1446 (2020).
CAS PubMed PubMed Central Google Scholar
Hojyo, S. et al. How COVID-19 induces cytokine storm with high mortality. Inflamm. Regener. 40(37), 1–7 (2020).
Google Scholar
Tisoncik, J. R. et al. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 76(1), 16–32 (2012).
CAS PubMed PubMed Central Google Scholar
Coperchini, F., Chiovato, L., Croce, L., Magri, F. & Rotondi, M. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 53, 25–32 (2020).
CAS PubMed PubMed Central Google Scholar
Lodowski, D. T. & Palczewski, K. Chemokine receptors and other G protein-coupled receptors. Curr. Opin. HIV AIDS 4(2), 88–95 (2009).
PubMed PubMed Central Google Scholar
Sinayskiy, I., Marais, A., Petruccione, F. & Ekert, A. Decoherence-assisted transport in a dimer system. PRL 108, 020602 (2012).
ADS CAS Google Scholar
Breuer, H. P. & Petruccione, F. The Theory of Open Quantum Systems (Oxford University Press, Oxford***, 2007).
MATH Google Scholar
Solov’yov, A. I., Chang, P. & Schulten, K. Vibrationally assisted electron transfer mechanism of olfaction: Myth or reality?. Phys. Chem. Chem. Phys. 14(40), 13861–13871 (2012).
PubMed PubMed Central Google Scholar
Huang, J. et al. On-site detection of SARS-CoV-2 antigen by deep learning-based surface-enhanced Raman spectroscopy and its biochemical foundations. Anal. Chem. 93(26), 9174–9182 (2021).
CAS PubMed PubMed Central Google Scholar
Fassioli, F., Dinshaw, R., Arpin, P. C. & Scholes, G. D. Photosynthetic light harvesting: Excitons and coherence. J. R. Soc. Interface 11, 20130901 (2014).
PubMed PubMed Central Google Scholar
Hippisley-Cox, J. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: Cohort study including 8.3 million people. Heart 106, 1503–1511 (2020).
CAS PubMed Google Scholar
Nunes, J. Mortality and use of angiotensin-converting enzyme inhibitors in COVID 19 disease: A systematic review. Porto Biomed. J. 5(6), e085 (2020).
PubMed PubMed Central Google Scholar
Abd El-Aziz, T. M., Al-Sabi, A. & Stockand, J. D. Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19. Sig. Transduct. Target Ther. 5, 258 (2020).
CAS Google Scholar
Yang, G. et al. Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: A single-center retrospective study. Hypertension 76(1), 51–58 (2020).
CAS PubMed Google Scholar
Derington, C. G. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One 16(4), e0248080 (2021).
CAS PubMed PubMed Central Google Scholar
Pirola, C. J. & Sookoian, S. Estimation of renin–angiotensin–aldosterone-system (RAAS)-inhibitor effect on COVID-19 outcome: A meta-analysis. J. Infect. 8(2), 276–281 (2020).
Google Scholar
Sriram, K. & Insel, P. A. G protein-coupled receptors as targets for approved drugs: How many targets and how many drugs?. Mol. Pharmacol. 93(4), 251–258 (2018).
CAS PubMed PubMed Central Google Scholar
Berg, K. A. & Clarke, W. P. Making sense of pharmacology: Inverse agonism and functional selectivity. Int. J. Neuropsychopharmacol. 21(10), 962–977 (2018).
CAS PubMed PubMed Central Google Scholar
Cheng, H. Inhibition of Ebola and Marburg virus entry by G protein-coupled receptor antagonists. J. Virol. 89(19), 9932–8 (2015).
CAS PubMed PubMed Central Google Scholar
Essa, M. M. Possible role of tryptophan and melatonin in COVID-19. Int. J. Tryptophan. Res. 13, 1178646920951832 (2020).
PubMed PubMed Central Google Scholar
Anderson, G., Carbone, A. & Mazzoccoli, G. Tryptophan metabolites and aryl hydrocarbon receptor in severe acute respiratory syndrome, coronavirus-2 (SARS-CoV-2) pathophysiology. Int. J. Mol. Sci. 22(4), 1597 (2021).
CAS PubMed PubMed Central Google Scholar
Delgado, P. L. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch. Gen. Psychiatry 51(11), 865–74 (1994).
CAS PubMed Google Scholar
Lenze, E. J. et al. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: A randomized clinical trial. JAMA 324(22), 2292–2300 (2020).
CAS PubMed PubMed Central Google Scholar
Hoertel, N., Sánchez-Rico, M., Vernet, R. et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: Results from an observational study. Mol. Psychiatry (2021).
Hamed, M. G. M. & Hagag,. The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients. R.S. Med Hypotheses 144, 110140 (2020).
CAS Google Scholar
Zuo, J. et al. Fluoxetine is a potent inhibitor of coxsackievirus replication. Antimicrob. Agents Chemother. 56(9), 4838–4844 (2012).
CAS PubMed PubMed Central Google Scholar
Benkahla, M. A., Alidjinou, E. K., Sane, F., Desailloud, R. & Hober, D. Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo. Antiviral Res. 159, 130–133 (2018).
CAS PubMed Google Scholar
McCorvy, J. D. & Roth, B. L. Structure and function of serotonin G protein-coupled receptors. Pharmacol. Ther. 150, 129–42 (2015).
CAS PubMed PubMed Central Google Scholar
Vasudevan, N. T., Mohan, M. L., Goswami, S. K. & Naga Prasad, S. V. Regulation of -adrenergic receptor function: An emphasis on receptor resensitization. Cell Cycle (Georgetown, Tex.) 10(21), 3684–3691 (2011).
CAS Google Scholar
Nuutinen, S. & Panula, P. Histamine in neurotransmission and brain diseases. Adv. Exp. Med. Biol. 709, 95–107 (2010).
CAS PubMed Google Scholar
Reznikov, L. R. et al. Identification of antiviral antihistamines for COVID-19 repurposing. Biochem. Biophys. Res. Commun. 538, 173–179 (2021).
CAS PubMed Google Scholar
Kabbani, N. Are nicotinic acetylcholine receptors coupled to G proteins?. BioEssays 35(12), 1025–34 (2013).
CAS PubMed Google Scholar
Govind, A. P., Vezina, P. & Green, W. N. Nicotine-induced upregulation of nicotinic receptors: Underlying mechanisms and relevance to nicotine addiction. Biochem. Pharmacol. 78(7), 756–765 (2009).
CAS PubMed PubMed Central Google Scholar
Changeux, J. Structural identification of the nicotinic receptor ion channel. Trends Neurosci. 41(2), 67–70 (2018).
CAS PubMed Google Scholar
Leung, J. M., Yang, C. X. & Sin, D. D. COVID-19 and nicotine as a mediator of ACE-2. Eur. Respir. J. 55, 2001261 (2020).
PubMed PubMed Central Google Scholar
Farsalinos, K. et al. Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: An expanded re-analysis of a recent publication. Harm Reduct. J. 18(9), 1–9 (2021).
Google Scholar
Nunn, A. V. W. et al. SARS-CoV-2 and mitochondrial health: Implications of lifestyle and ageing. Immun. Ageing 17, 33 (2020).
CAS PubMed PubMed Central Google Scholar
Chernyak, B. V. et al. COVID-19 and oxidative stress. Biochem. Biokhimiia. 85(12), 1543–1553 (2020).
CAS Google Scholar
Forcados, G. E. et al. Metabolic implications of oxidative stress and inflammatory process in SARS-CoV-2 pathogenesis: Therapeutic potential of natural antioxidants. Front. Cell. Infect. Microbiol., (2021).
Lei, Y. et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ. Res. 128, 1323–1326 (2021).
CAS PubMed PubMed Central Google Scholar
Riya, G. & Hemachandra, R. P. Impact of COVID-19 on mitochondrial-based immunity in aging and age-related diseases. Front. Aging Neurosci. 12, 502 (2021).
Google Scholar
Paul, B. D., Lemle, M. D., Komaroff, A. L. & Snyder, S. H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. PNAS 118(34), e2024358118 (2021).
CAS PubMed PubMed Central Google Scholar
Callard, F. & Perego, E. How and why patients made Long Covid. Soc. Sci. Med. 268, 113426 (2021).
PubMed PubMed Central Google Scholar
Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27, 601–615 (2021).
CAS PubMed PubMed Central Google Scholar
Nabavi, N. Long covid: How to define it and how to manage it. BMJ 370, m3489 (2020).
PubMed Google Scholar
Ladds, E. et al. Persistent symptoms after Covid-19: Qualitative study of 114 “long Covid” patients and draft quality principles for services. BMC Health Serv. Res. 20(1144), (2020).
Marshall, M. The lasting misery of coronavirus long-haulers. Nature 585, 339–341 (2020).
ADS CAS PubMed Google Scholar
del Rio, C., Collins, L. F. & Malani, P. Long-term health consequences of COVID-19. JAMA 324(17), 1723–1724 (2020).
PubMed PubMed Central Google Scholar
Bannister, B. A. Post-infectious disease syndrome. Postgrad. Med. J. 64(753), 559–567 (1988).
CAS PubMed PubMed Central Google Scholar
Archer, M. I. The post-viral syndrome: A review. J. R. Coll. Gen. Pract. 37(298), 212–214 (1987).
CAS PubMed PubMed Central Google Scholar
Underhill, R. & Baillod, R. Myalgic encephalomyelitis/chronic fatigue syndrome: Organic disease or psychosomatic illness? A re-examination of the royal free epidemic of 1955. Medicina (Kaunas) 57(1), 12 (2020).
Google Scholar
Friedman, K. J. Advances in ME/CFS: Past, present, and future. Front. Pediatr. 7, 131 (2019).
PubMed PubMed Central Google Scholar
Johnston, S. S. D., Klein, A. & Marshall-Gradisnik, S. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. BMC Med. Genet. 17(1), 1–7 (2016).
Google Scholar
Loebel, M. G. et al. Antibodies to b adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav. Immun. 52, 32–39 (2016).
CAS PubMed Google Scholar
Wirth, K. & Scheibenbogen, C. A unifying hypothesis of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors. Autoimmun. Rev. 19(6), 102527 (2020).
CAS PubMed Google Scholar
Adiliaghdam, F. & Jeffrey, K. L. Illuminating the human virome in health and disease. Genome Med. 12, 66 (2020).
PubMed PubMed Central Google Scholar
Nieva, J., Madan, V. & Carrasco, L. Viroporins: Structure and biological functions. Nat. Rev. Microbiol. 10, 563–574 (2012).
CAS PubMed PubMed Central Google Scholar
Scott, C. & Griffin, S. Viroporins: Structure, function and potential as antiviral targets. J. Gen. Virol. 96(8), 2000–2027 (2015).
CAS PubMed Google Scholar
Chaudhuri, A., Watson, W. S., Pearn, J. & Behan, P. O. The symptoms of chronic fatigue syndrome are related to abnormal ion channel function. Med. Hypotheses 54(1), 59–63 (2000).
CAS PubMed Google Scholar
Mandala, V. S. et al. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat. Struct. Mol. Biol. 27, 1202–1208 (2020).
CAS PubMed PubMed Central Google Scholar
Schoeman, D. & Fielding, B. C. Coronavirus envelope protein: Current knowledge. Virol. J. 16(69), 1–22 (2019).
CAS Google Scholar
Abdul, K. L., Stacey, M. & Barrett-Jolley, R. Emerging roles of the membrane potential: Action beyond the action potential. Front. Physiol. 9, 1661 (2018).
Google Scholar
Chernet, B. T. & Levin, M. Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model. Dis. Model. Mech. 6(3), 595–607 (2013).
CAS PubMed PubMed Central Google Scholar
Nilsson, I. et al. Metabolic dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome not due to anti-mitochondrial antibodies. Front. Med. (Lausanne) 31(7), 108 (2020).
Google Scholar
Tomas, C. & Newton, J. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: A mini-review. Biochem. Soc. Trans. 46(3), 547–553 (2018).
CAS PubMed Google Scholar
Quinzii, C. M. & Hirano, M. Coenzyme Q and mitochondrial disease. Dev. Disabil. Res. Rev. 16(2), 183–188 (2010).
PubMed PubMed Central Google Scholar
Hargreaves, I. P. Coenzyme Q10 as a therapy for mitochondrial disease. Int. J. Biochem. Cell Biol. 49, 105–11 (2014).
CAS PubMed Google Scholar
Chen, X., Zhang, J., Mihai, D. M. & Washington, I. Light-harvesting chlorophyll pigments enable mammalian mitochondria to capture photonic energy and produce ATP. J. Cell Sci. 127, 388–99 (2015).
Google Scholar
Buehler, M. J. Nanomechanical sonification of the 2019-nCoV coronavirus spike protein through a materiomusical approach. arXiv: Popular Physics (2020).
Zhang, D. Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in environmental specimens via surface enhanced Raman scattering (SERS). medRxiv 2020.05.02.20086876.
Jinglin, H. et al. Detection of spike protein of SARS-CoV-2 by surface enhanced Raman spectroscopy. High Power Laser Part. Beams 32, 069001 (2020).
Google Scholar
Li, Q. et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell 182, 1284–1294 (2020).
CAS PubMed PubMed Central Google Scholar
Ushio-Fukai, M. Vascular signaling through G protein-coupled receptors: New concepts. Curr. Opin. Nephrol. Hypertens. 18(2), 153–159 (2009).
CAS PubMed PubMed Central Google Scholar
Auten, R. & Davis, J. Oxygen toxicity and reactive oxygen species: The devil is in the details. Pediatr. Res. 66, 121–127 (2009).
CAS PubMed Google Scholar
Usselman, R. et al. The quantum biology of reactive oxygen species partitioning impacts cellular bioenergetics. Sci. Rep. 6, 38543 (2016).
ADS CAS PubMed PubMed Central Google Scholar
Tay, M. Z. et al. The trinity of COVID-19: Immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363–374 (2020).
CAS PubMed PubMed Central Google Scholar
Doykov, I., Hällqvist, J., Gilmour, K. C. et al. The long tail of Covid-19—The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients [version 2; peer review: 2 approved]. F1000Research9, 1349 (2021).
Pooam, M., Aguida, B., Drahy, S., Jourdan, N. & Ahmad, M. Therapeutic application of light and electromagnetic fields to reduce hyper-inflammation triggered by COVID-19. Commun. Integr. Biol. 14(1), 66–77 (2021).
CAS PubMed PubMed Central Google Scholar
Download references
B.A, I.S. and F.P. were supported by the South African Research Chair Initiative of the Department of Science and Technology and the National Research Foundation. Thank you to Angela Illing for the diagrams.
School of Chemistry and Physics, University of KwaZulu-Natal, Durban, South Africa
Betony Adams, Ilya Sinayskiy & Francesco Petruccione
The Guy Foundation, Dorset, UK
Betony Adams
National Institute for Theoretical and Computational Sciences (NITheCS), Stellenbosch, South Africa
Betony Adams, Ilya Sinayskiy & Francesco Petruccione
Department of Biophysics, Faculty of Sciences, VU University Amsterdam, De Boelelaan, 1081 HV, Amsterdam, The Netherlands
Rienk van Grondelle
School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, 7604, South Africa
Francesco Petruccione
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
All authors conceptualised the manuscript. B.A. wrote the text. I.S. and B.A. developed the simulations. All authors reviewed and edited the manuscript.
Correspondence to Betony Adams.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Reprints and Permissions
Adams, B., Sinayskiy, I., van Grondelle, R. et al. Quantum tunnelling in the context of SARS-CoV-2 infection. Sci Rep 12, 16929 (2022). https://doi.org/10.1038/s41598-022-21321-1
Download citation
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-21321-1
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
Advertisement
© 2022 Springer Nature Limited
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
Big Week In Religion News: From Loretta Lynn To Aaron Judge, 9 Names To Know – Religion Unplugged
A post shared by Scottie Scheffler (@scottie.scheffler)
Editor’s note: Every Friday, “Weekend Plug-in” features analysis, fact checking and top headlines from the world of faith. Subscribe now to get this newsletter delivered straight to your inbox. Got feedback or ideas? Email Bobby Ross Jr. at [email protected].
(ANALYSIS) A country music queen. A home run king.
A former White House press secretary. A current U.S. Supreme Court plaintiff.
In a busy week for religion news, they are among nine names to know (in alphabetical order):
• Bart Barber: I’m showing a little bias here because I wrote this week’s Associated Press profile of Barber, a small-town Texas pastor and rancher elected to lead the 13.7 million-member Southern Baptist Convention at a time of major crisis. Barber will be featured Sunday night in a “60 Minutes” interview with Anderson Cooper.
It’s cool to see my @AP profile of @bartbarber on the front page of today’s @Tennessean, the newspaper that gave us @bobsmietana, @HollyAMeyer and @liamsadams. https://t.co/HoYZhsG6Cc pic.twitter.com/sLF0VixPNu
• Chris Jones and Sarah Huckabee Sanders: Jones is the Democrat and Sanders the Republican in Arkansas’ gubernatorial race. “With two preachers’ kids and a pastor in the race, Arkansans are poised to elect a governor who can sing hymns by heart and quote Scripture from memory,” the Arkansas Democrat-Gazette’s Frank Lockwood writes as he delves into faith and politics. (Sanders served as former President Donald Trump’s White House press secretary from 2017 to 2019.)
• Aaron Judge: The New York Yankees star made history when he hit his 62nd home run of the season Tuesday night. Prayer and faith played a key role during Judge’s chase, reports the Deseret News’ Ryan McDonald.
• Loretta Lynn: The country music superstar and Kentucky coal miner’s daughter died Tuesday at age 90. “She really was serious about her faith and a devout member of the church,” retired minister Terry Rush, who maintained a close friendship with Lynn, told me.
The faith of Loretta Lynn https://t.co/QccLuGsKE6
• John Henry Ramirez: The Texas killer fought all the way to the U.S. Supreme Court to have his pastor lay hands on him and pray during his execution. “Just know that I fought a good fight, and I am ready to go,” Ramirez said before his death by lethal injection Wednesday, as noted by The Associated Press’ Juan A. Lozano and Michael Graczyk.
• Lorie Smith and Jack Phillips: The two claim in an opinion piece for USA Today that Colorado is trampling on their First Amendment rights as Christian artists, and they’re fighting back. Website designer Smith’s case is headed to the U.S. Supreme Court, the Deseret News’ Kelsey Dallas reports. Phillips, a baker who already won a partial high court victory, is challenging a new state ruling, AP’s Colleen Slevin notes.
• Herschel Walker: Despite the Georgia Republican’s denials, an allegation that the U.S. Senate candidate and former Heisman Trophy winner paid for a girlfriend’s abortion in 2009 has engulfed his campaign. Religion News Service’s Jack Jenkins and Politico’s Natalie Allison report on religious leaders’ responses.
Herschel Walker’s Christian fans say they care more about his policies than the allegation that the self-described “pro-life” Republican paid for an ex-girlfriend’s abortion in 2009.https://t.co/ExwWY5MYBY
1. These Floridians gathered for church in Fort Myers. They brought their Hurricane Ian survival stories: A journalist going to church on the Sunday after a major natural disaster inevitably generates a compelling story, as USA Today’s Chris Kenning illustrates.
Ian shook southwest Florida’s faith but couldn’t destroy it, The Associated Press’ Bobby Caina Calvan, Giovanna Dell’Orto and Robert Bumsted report. Amid Ian’s wounds, Jews saw healing and renewal in Yom Kippur, AP’s Calvan and Mike Schneider explain.
In case you missed it, last week’s Plug-in highlighted the important role of the “faith-based FEMA.”
The senior pastor said God had protected those who sheltered in the church: “It was almost like the ark.”https://t.co/qRIb6MAH8i
2. On game day, some see prayer as a Hail Mary: “While appeals to the divine are not a fundamental part of most sports fans’ playbooks, (Dolores) Mejia and others like her believe prayer has the power to influence who goes home the victor,” The Associated Press’ Holly Meyer reports in this fun feature.
“About 3 in 10 U.S. adults say they believe it can play a role in determining who wins a sporting event, and a similar percentage say God plays a role, according to a new poll from The Associated Press-NORC Center for Public Affairs Research.”
What do you think @UTKnoxville fans? WWJD?
“I could very much see Jesus sitting in Neyland Stadium watching a great game and cheering, but not manipulating the outcome.”https://t.co/whDCxiSXg9
3. For believers, a day of atonement. For others, a giant playground: “Yom Kippur, the holiest day in Judaism, brings Israel to a standstill,” the New York Times’ Patrick Kingsley reports. “For the nonobservant, that briefly turns highways into bike trails.”
Kingsley and photographer Amit Elkayam offer a colorful dispatch from Highway 1, the main thoroughfare between Jerusalem and Tel Aviv.
Some pray and repent, others take to the empty highways on roller-blades. Yom Kippur, the quietest day of the year in the holy land
by @PatrickKingsley photos by Amit Elkayam https://t.co/3JR4bjhKIa
• After the Boomers, new leaders bring new life to the Vineyard (by Daniel Silliman, Christianity Today)
• Iranian women at home and abroad cut their hair to protest Mahsa Amini’s death (by Sarah Parvini, Los Angeles Times)
I wrote about women in Iran and in diaspora cutting their hair in solidarity with the #MahsaAmini #IranProtests2022 + looked at why this movement — lead by women, w/ support from broad cross sections of Iranian society — feels different from protests past https://t.co/HTo33FEnYH
• Episcopal priest the Rev. David Sibley becomes four-time ‘Jeopardy!’ champion (by Emily McFarlan Miller, Religion News Service)
• Two prophets, century-old prayer duel inspire Zion mosque (by Deepa Bharath, Associated Press)
• 70 years later, ‘Power of Positive Thinking’ finds new generation of readers (by Mark A. Kellner, Washington Times)
• ‘You can’t cancel me’: embattled TikTok star reinvents herself as a warrior for Jesus (by Jess McHugh, Guardian)
This was one of those rare stories where the more you dig, the weirdest it gets: an alleged $1M fitness fraud, Lady Gaga as an actual witch, an ACLU lawsuit, a dead dog…
Read my latest on Brittany Dawn, from @guardian https://t.co/auhWG6bqHe
• French feminist rabbi captivates multifaith crowds with musings on mortality (by Julia Lieblich, New York Times)
• The Satanic Temple takes aim at Idaho, Indiana abortion bans (by Rebecca Boone, AP)
• Mormon leader, 98, acknowledges aging as he sits at podium during two-day event (by Mark A. Kellner, Washington Times)
• Think piece: An interfaith journey to forge ties between Israel and Pakistan (by BeLynn Hollers, RNS)
• Think piece: Why growing parts of the Christian right are convinced it’s the apocalypse (by Molly Olmstead, Slate)
The Apocalypse Is Sweeping Christian Books—and Bestseller Lists | @Slate https://t.co/92FNXvTt7L pic.twitter.com/0zVfAvlwyw
Cecile S. Holmes was a veteran religion reporter, editor, journalism professor and interfaith champion, as Religion News Service’s Yonat Shimron reports. After an illness, she died Sept. 29 in Columbia, South Carolina, at age 67.
The great Cecile Holmes–former @ReligionReport president, teacher, and journalist with a great sense of humor and a champion of interfaith work– has died. She was a friend to many reporters and will be missed.https://t.co/luOMEdGsYc
The Religion News Association board of directors offered condolences to Holmes’ family, friends, colleagues and admirers.
“The RNA community grieves the loss of Cecile Holmes, who was RNA president from 1996 to 1998 and recipient of RNA’s William A. Reed Lifetime Achievement Award in 2016,” the board’s statement said. “Cecile was on the religion beat for three decades, starting as the religion and food writer at the Greensboro (N.C.) News and Record and later working as a longtime correspondent for Religion News Service and as an award-winning religion editor at the Houston Chronicle. She also taught journalism at the University of South Carolina School of Journalism and Mass Communications.”
Here is where you can catch up on recent news and opinions from ReligionUnplugged.com.
• Faith, family and the dropping number of marriages (Part II) (by Terry Mattingly)
• Modi government’s ban of controversial Muslim organization Popular Front of India worries critics (by Shadab Farooq)
• Former WWE’s million-dollar man hasn’t repaid welfare funds misused by ministry (by Steve Rabey)
• International community is failing the Uyghurs, but a change may be ahead (by Ewelina U. Ochab)
(ANALYSIS/@pardismahdavi) Shouts of “death to the dictator” and “woman, life, freedom” are reverberating through the streets of Iran after the death of Mahsa Amini, a 22-year-old woman, while in custody of the “morality police” in Tehran.https://t.co/FWbI5sqeBc #IranProtests
• Iranian women have been rebelling since the 1979 Islamic Revolution (by Pardis Mahdavi)
• Faith and politics: Italian election coverage loaded with Meloni media baloney (by Clemente Lisi)
• Majority of Catholics say Biden should not seek second White House bid, poll reveals (by Clemente Lisi)
• Whatever you believe about history is likely wrong (by Paul Prather)
• Pope Francis makes passionate plea for Putin to end cycle of ‘violence and death’ in Ukraine (by Clemente Lisi)
Pope Francis appealed to Russia Pres. Vladimir Putin Sunday to end the military escalation in Ukraine and “stop this spiral of violence and death.” The pontiff added he was “saddened at the immense suffering of the Ukrainian people.” From @ClementeLisi:https://t.co/EEu6prUevZ
• Season 3 of Muslim comedy ‘Ramy’ gives viewers a ‘spiritual discretion’ warning — here’s why (by Jillian Cheney)
• Zimbabwean government blames religious anti-vaxxers for deadly measles outbreak (by Cyril Zenda)
Forsyth County, Georgia, which remained nearly all-White into the 1990s, has an ugly racial history.
Two Atlanta-area churches say it’s past time to write a better, more racially inclusive story for the future.
“It’s good to be in Forsyth County this morning!” proclaimed minister Kelvin Teamer.
“Amen! Amen!” the crowd responded.
“Now there was a time not long ago,” the Black minister added, “when somebody who looked like me would never say anything like that."https://t.co/Xy9HgIwbVF
I made a quick trip to the Peach State this past weekend to report the news for The Christian Chronicle.
Happy Friday, everyone! Enjoy the weekend.
Bobby Ross Jr. is a columnist for ReligionUnplugged.com and editor-in-chief of The Christian Chronicle. A former religion writer for The Associated Press and The Oklahoman, Ross has reported from all 50 states and 15 nations. He has covered religion since 1999.
Religion Unplugged
56 Broadway
New York, NY 10004
212-659-0742
[email protected]
Religion Unplugged is a production of The Media Project and a member of the Institute for Nonprofit News
EIN: 83-046145
site design by Peter Freeby
Donald Trump Is Reportedly Regretting His Demand For Special Master In His DOJ Case: ‘Giant Backfire’ – SheFinds
Celebrity
According to legal experts, Donald Trump may have made a critical mistake by asking a judge to intervene in the criminal investigation into his collecting of government documents. By appointing a special master— experts who spoke to the New York Times explain— this could lead to a major “backfire” costing the twice-impeached former president more than he might have expected.
Peter M. Shane, a legal scholar in residence at New York University and a specialist in separation-of-powers law said to the Times, “Maybe from Trump’s point of view, creating delay and chaos is always a plus, but this has the feel of a giant backfire.” Initially, NYT writer Charlie Savage notes that Trump’s demand that an outside arbiter sift through the materials the F.B.I. seized from his Florida estate “seemed to turn in his favor.” His lawsuit was assigned to Aileen M. Cannon of the Southern District of Florida, a judge he had appointed himself. She surprised legal experts across the nation when she granted his shocking request.
Lawyers for former President Donald Trump called upon the Supreme Court to reverse an appeals court ruling that reversed a lower court ruling allowing for a special master to review allegedly classified documents seized at Mar-a-Lago. https://t.co/86BrTYpw1l
— MarineGun1791 (@DonDonMarshall1) October 4, 2022
Donald Trump’s attorneys have gone to the Supreme Court and requested that it intervene and allow the special master to look at all of the material seized from Mar-a-Lago, including classified documents. pic.twitter.com/fsT0CGxEh9
— The Recount (@therecount) October 4, 2022
Cannon effectively froze the Justice Department’s investigation into Trump, and gave the arbiter a broad mandate by naming the special master that was suggested by Trump’s lawyers. The judge, Raymond J. Dearie of Federal District Court for the Eastern District of New York, would filter the materials “not just for attorney-client privilege, which is not unusual,” Savage writes, but also for “executive privilege, which is unprecedented.”
However, the tides turned last month when both an appeals court ruling and a letter the Justice Department about subsequent complaints Trump’s legal team filed under seal to Judge Dearie imply that the positive aspects to getting a special master are not what they may have seemed. One of Trump’s lawyers, James Trusty did not respond to a request for comment from the Times, but later last week, Trump’s team refiled its complaints to the judge, which Savage writes, brought “the tensions more clearly into view.”
This Friday is the “put up or shut up” date for Donald Trump’s claim that the FBI planted evidence at Mar-a-Lago, per the Special Master, Judge Raymond Dearie. By then Trump must identify WHICH seized materials were “planted.” Yeah, right.
— Laurence Tribe (@tribelaw) September 27, 2022
Donald Trump and his lawyers thought it would be a great idea to request a special master in the Mar-a-Lago classified documents case.
The gambit appears to be backfiring. -MaddowBlog https://t.co/uPmHDhdour
— MSNBC (@MSNBC) September 30, 2022
Last week, the appeals court then allowed the Justice Department to continue analyzing around 100 documents marked as classified in its investigation, while, Savage notes, “telegraphing that the court thought Judge Cannon likely had erred by appointing a special master.” The appeals court panel blocked Judge Cannon’s order, which means that they, including two Trump appointees, allowed investigators to again look into the material that poses “by far the gravest legal threat to Mr. Trump,” as Savage writes.
Potential crimes include “unlawful retention of national security secrets, obstruction and defying a subpoena demanding all sensitive records that remained in his possession.” Savage adds, “Since that review is no longer delaying or diverting the criminal inquiry, it is not clear what benefits remain for Mr. Trump.”
Essentially, Julie O’Sullivan, a Georgetown University professor of white-collar law tells the times that Judge Dearie is telling Trump’s legal team “to put up or shut up.” She continued, “They thought it was a win to win the first battle, but they didn’t think through what winning that battle would mean with any reputable judge who is appointed as special master.” O’Sullivan added, “They can’t anticipate that every judge will give them a complete pass despite the law. It was a political or a public relations strategy, not a legal one.”
Tags:
Author: SHEfinds Editors
The SheFinds Editorial Team scours the web to find the best in fashion and beauty so that our busy readers don’t have to. We’re online shopping junkies to the core. You can reach us via email [email protected]
New symptoms and prevalence of postacute COVID-19 syndrome among nonhospitalized COVID-19 survivors | Scientific Reports – Nature.com
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
Scientific Reports volume 12, Article number: 16921 (2022)
Metrics details
The aim of this study was to assess postacute coronavirus disease 2019 (COVID-19) syndrome (PACS) symptoms according to the onset of the infection while evaluating the effect of COVID-19 vaccination on the symptoms of PACS. We conducted a retrospective single-center cohort study in which nonhospitalized COVID-19 survivors and healthy controls were compared for the occurrence of PACS. The total number of patients in this study was 472. At 6–12 and > 12 months after the infection, COVID-19 survivors had a significantly higher incidence of posttraumatic stress disorder (PTSD) and anxiety than the non-COVID-19 cohort. Furthermore, depression, cognitive deficit, tics, impaired quality of life and general health impairment were significantly more prevalent among COVID-19 survivors at < 6 months, 6–12 months and > 12 months than in the non-COVID-19 cohort. However, respiratory symptoms were significantly more prevalent among COVID-19 survivors only in the first 6 months after infection. In addition, cognitive deficit (OR = 0.15; 95% CI 0.03–0.87) and impaired quality of life (B = − 2.11; 95% CI − 4.21 to − 0.20) were significantly less prevalent among vaccinated COVID-19 survivors than among nonvaccinated survivors. Longitudinal studies are needed to establish the time that should elapse after COVID-19 infection for the symptoms of PACS to appear. Randomized clinical trials are needed to assess the possibility that COVID-19 vaccines might relieve PACS symptoms.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues to be a major public health burden and is responsible for significant morbidity and mortality, with upward of 260 million cases reported worldwide at present. The symptoms of acute illness range from mild to severe, with a wide range of possible symptoms presenting 2–14 days after exposure1,2.
It was reported early in the pandemic that the COVID-19 fatality rate was 1–5%3; however, the rapid spread of the virus resulted in deleterious effects on public health and expectations of a potential drop in life expectancy worldwide in different magnitudes depending on the region4. The enormous mortality toll of the pandemic resulted in projections of a decline in life expectancy of more than 1 year in the United States5. In addition to the mortality toll, the persistence of symptoms beyond four weeks of the initial episode was reported in a large proportion of the affected patients and collectively called postacute COVID-19 syndrome (PACS). This term encompasses a wide range of symptoms that appear after infection and lasts weeks to months, including new or ongoing symptoms, multiorgan effects of COVID-19 and the effects of COVID-19 treatment or hospitalization6,7. The most commonly reported manifestations include general, respiratory, cardiovascular, neurological, gastrointestinal, musculoskeletal, psychiatric and dermatological symptoms, among others8,9.
Several factors were implicated in increasing the likelihood of developing PACS. Some of these factors included the COVID-19 course, sex and the survivor’s past medical history10. A more severe COVID-19 course was associated with the development of subsequent neurological, pulmonary, musculoskeletal, and psychiatric diagnoses and general fatigue10,11, whereas milder cases were associated with the development of anosmia and ageusia10. The presence of more than five symptoms in the first week of illness was also associated with PACS9. Additionally, persistent fatigue, psychological symptoms, and other sequelae were more likely to occur in women8,9. Other individuals who had an increased risk of PACS were young/middle-aged patients, patients above the age of 70, and patients with multiple comorbidities12,13.
It was estimated that more than 40% of COVID-19 survivors suffer from PACS13. In addition, a recent meta-analysis demonstrated that the highest prevalence of PACS was in Asia, with a prevalence of 49%13. The studies performed regarding PACS indicated that COVID-19 survivors might suffer from long-term debilitating symptoms after their recovery12. Although several studies have characterized these symptoms, most of them were performed on hospitalized COVID-19 patients, and new symptoms are still being reported, such as movement disorders14. In addition, the duration of time that should elapse for these symptoms to subside has not yet been studied. Moreover, online polls among patients with PACS showed that patients reported a reduction in their symptoms after receiving the COVID-19 vaccine15. Furthermore, several studies reported an increase in tics and tic-like symptoms during the COVID-19 pandemic, yet no studies have investigated their association with COVID-19 infection16.
The primary aims of this study were to assess PACS symptoms among nonhospitalized COVID-19 patients, including quality of life, cognitive function, tic symptoms, respiratory symptoms, posttraumatic stress disorder, anxiety and depression, and to evaluate these symptoms according to the time of COVID-19 infection by comparing nonhospitalized COVID-19 survivors with non-COVID-19 controls as well as to report the newly reported symptoms of PACS (tics). The secondary aim was to evaluate the effect of the COVID-19 vaccine on PACS symptoms.
A retrospective cohort study was conducted at Jordan University Hospital (JUH), a tertiary hospital located in Amman, Jordan. The current population of Jordan is 10,909,567, of whom 53.1% are men. The median age of the Jordanian population is 23.5 years. Regarding comorbidities, approximately 15% of the Jordanian population has diabetes, and 20% of the population has hypertension. The participants were recruited by convenience sampling of patients at JUH. All patients admitted to the hospital ward not due to or during the COVID-19 infection or who visited the outpatient clinics between September 29th and November 11th, 2021, were eligible to participate in this study. Two cohorts were included in the study: (1) all COVID-19 survivors who were not hospitalized due to COVID-19 or during the COVID-19 infection period regardless of the interval between infection and enrollment in this study and (2) all individuals who never tested positive for COVID-19. The ascertainment of COVID-19 infection was based on reverse transcription polymerase chain reaction (RT-PCR) nasopharyngeal swab results. The history of COVID-19 infection was evaluated in multiple steps. First, the patient was asked about a history of a positive RT-PCR swab for COVID-19 and whether the patient underwent the test at our institution or elsewhere. If the patient underwent the test at our institution, the test result was confirmed using medical records. If the patient underwent the test outside our institution, the patient was asked to provide the confirmatory test results sent by the Jordanian Ministry of Health to the patient’s phone. Self-reported results without confirmatory tests were not accepted, and the patient was subsequently excluded from the study. Patients were excluded if they were hospitalized due to or during the COVID-19 infection, did not agree to participate, withdrew their consent anytime during the interview, had missing data regarding infection and vaccination status or had psychiatric or dementia disorders based on the medical records regardless of the severity of the disorder. This study was approved by the Institutional Review Board at JUH (IRB#202123152), and the participants were provided with the aims of the study prior to the initiation of the interview. Written informed consent was obtained from all patients who agreed to participate in the study. This research was conducted in accordance with the Declaration of Helsinki regulations and its relevant guidelines.
The data were collected using structured face-to-face interviews administered by the members of the research team, who were trained to interview patients via online and face-to-face sessions prior to the conduction of the study. The training involved explanation of the interview questions as well as multiple simulations of the interview procedure in the hospital setting. The data collection process was composed of two steps. The first step was to interview the patients who agreed to participate for the occurrence of PACS symptoms and the presence of tics. PACS components were assessed using eight scales, including the EuroQol five-dimension five-level assessment (EQ-5D-5L), EuroQol Visual Analogue Scale (EQ-VAS), Impact of Event Scale (IES-6), Generalized Anxiety Disorder 7-item scale (GAD-7), Patient Health Questionnaire 9 (PHQ-9), Modified Medical Research Council scale (mMRC), Breathlessness, Sputum and Cough Scale (BCSS), and Montreal Cognitive Assessment (MoCA)17,18,19,20,21,22,23. These scales were shown to comprehensively screen for PACS symptoms among COVID-19 survivors by Johns Hopkins Hospital24. Patient characteristics were extracted from the hospital electronic medical system (EMS), including (1) patient demographics (age, sex and body mass index (BMI)), (2) past medical history, (3) actively prescribed medications extracted from the patient medical records profile and patients’ pharmacy refills in the past 3 months, (4) history of COVID-19 infection and date of that infection, (5) COVID-19 vaccination status, and (6) Hospitalization status during the interview which was done after the patient recovery from the COVID-19 infection. It is important to mention that hospitalization status during the COVID-19 infection was not part of the data collection procedure as any patient hospitalized during the COVID-19 infection period was excluded from the study.
The primary outcomes were quality of life assessed by the EQ-5D-5L assessment, general health status assessed by the EQ-VAS, cognitive function assessed by the MoCA, and tic symptoms and respiratory symptoms assessed by the BCSS and mMRC scale, respectively. The secondary outcomes were posttraumatic stress disorder (PTSD) assessed by the IES-6, anxiety assessed by the GAD-7 scale, and depression assessed by the PHQ-9. The EQ-5D-5L assessment describes five domains for quality of life, namely, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each of these aspects is scored from 1 to 5, with higher scores indicating higher impairment for each domain. The aforementioned domains were used to calculate the EQ-5D-5L index value, which is a valid index that estimates overall quality of life25. The EQ-5D-5L index ranges between 0 and 1, with higher scores indicating lower quality of life25. The way of calculating the index value is described in Supplementary Material 1. The EQ-5D-5L assessment also includes a vertical visual analog scale (EQ-VAS) that allows participants to grade their perceived health on the day of the interview on a scale from 0 to 100, with higher scores indicating better subjective health23. The MoCA is a validated tool that assesses mild cognitive impairment (MCI) with 92.3% sensitivity and 85.7% specificity. The maximum possible score that can be achieved is 30, with a score below 26 indicating MCI19. The tics were assessed among the participants by asking them whether they had experienced repetitive movements. Whenever a patient with a history of COVID-19 infection experienced such movements, the patient was asked whether these movements were experienced prior to or after a positive COVID-19 test. Additionally, the patients were asked about the nature of the experienced movements in addition to a previous history of movement or tic-related disorders. Patients in both cohorts were considered to be positive for tic assessment if they experienced repetitive movements and did not have any history of movement disorder. COVID-19 survivors were considered positive for tic assessment if they met the aforementioned criteria in addition to experiencing these symptoms after a positive test for the COVID-19 survivor cohort. Furthermore, the BCSS is a 3-item instrument that rates breathlessness, cough and sputum on a 5-point Likert scale graded from 0 to 4, where 0 indicates no symptoms and 4 indicates severe symptoms18. Additionally, the mMRC scale was used to assess respiratory symptoms. This scale is composed of 5 items and is used to determine the associated disability and impact of breathlessness on everyday life, graded from 0 to 4, with higher scores indicating more severe symptoms22. The IES-6 is an instrument used to screen for PTSD that results from any stressful event, including trauma, natural disasters, personal events and chronic comorbidities. A cutoff score of 1.75 has a sensitivity of 88% and a specificity of 85% in identifying PTSD17. The GAD-7 scale is a valid instrument used to screen for anxiety, with a cutoff point of 10 or greater having a sensitivity of 89% and specificity of 82%20. Finally, the PHQ-9 is an instrument that is used to assess symptoms of depression. Its cutoff score for diagnosing depression of 8 or higher has a sensitivity of 88.2% and a specificity of 86.6%21. Moreover, patients who scored > 1.75 on the IES-6, ≥ 10 on the GAD-7 scale and ≥ 8 on the PHQ-9 were considered positive for PTSD, anxiety and depression, respectively. The COVID-19 survivors were stratified into 3 categories according to the duration between infection and interview: < 6 months, 6–12 months and > 12 months to demonstrate the changes in the prevalence of PACS symptoms with time. In addition, the COVID-19 survivors were categorized according to their vaccination status into vaccinated and unvaccinated groups, and the effect of vaccination on PACS symptoms was tested. Patients had to receive the initial series doses to be considered vaccinated (2 doses of Pfizer or Sinopharm vaccine or 1 dose of Johnson & Johnson) regardless of whether they received a booster shot. Vaccination status and the received vaccine types had to be confirmed by the patient through a vaccine certificate provided by the Jordanian Ministry of Health.
Data analysis was performed using IBM SPSS v.25. Demographic characteristics were summarized using percentages for categorical variables and the means with their corresponding standard deviations for continuous variables. Chi-square and t tests were used to assess the differences in the demographic characteristics and outcome measures between the COVID-19 survivors and the non-COVID-19 cohorts. Also, Odds Ratio (OR) and Cohen’s d were used as effect measures to estimate the differences in the categorical and continuous demographic variables, respectively between COVID-19 survivors and non-COVID-19 cohort. Multivariate logistic and linear regression models were used to assess the effect of COVID-19 infection on the outcomes. Furthermore, to identify the pattern of PACS symptom prevalence changes with time, COVID-19 infection durations (< 6 months, 6–12 months and > 12 months) were compared for the presence of PACS symptoms with the non-COVID-19 cohort as a control group (reference) using multivariate logistic and linear regression models. In addition, to examine the effect of vaccination on PACS symptoms, a comparison of the occurrence of PACS symptoms between the vaccinated and unvaccinated COVID-19 survivor groups was performed using multivariate logistic and linear regression models. These models were adjusted for age, sex, BMI, hospitalization status during the interview, comorbidities (diabetes mellitus, respiratory comorbidities, cardiovascular comorbidities, Chronic Kidney Disease (CKD), cancer, autoimmune diseases, Gastrointestinal disorders, neurological diseases, and others) and medication use (antidiabetic drugs, antihypertensives, antiplatelets/anticoagulants, inhalers, dyslipidemia drugs, Proton Pump Inhibitors (PPIs)/H2 blockers and others). All significance tests were two-sided, and a P value of less than 0.05 was considered statistically significant. P-values were not adjusted for multiple comparison as studies showed that although adjustments reduce type I error frequency, it increases the risk of type II error26.
We invited 730 patients to participate in this study, among whom 200 refused to participate, 22 withdrew their consent during the interview and 36 were excluded because they had psychiatric or dementia disorders or because they were missing data regarding infection and vaccination status. The participants flow diagram is described in Supplementary Material 2. The total number of participants who completed the interview was 472, with a response rate of 64.7%. Among those patients, 26.5% were COVID-19 survivors (125/472), while the rest had never tested positive for COVID-19. The majority of the COVID-19 patients were infected > 12 months before the interview (43.2%). However, 28.8% and 28.0% were infected < 6 months and 6–12 months before the time of the assessment, respectively.
The COVID-19 and non-COVID-19 control groups were comparable in all demographic characteristics except for sex and smoking status (P value = 0.008 and 0.016, respectively). The percentage of men in the non-COVID-19 group (64.0%) was significantly higher than that in the COVID-19 group (50.4%). In addition, the percentage of smokers (42.7%) was significantly higher in the non-COVID-19 group than in the COVID-19 group (30.4%). Furthermore, there were no significant differences between the COVID-19 and non-COVID-19 groups in terms of comorbidities or medication use except for GI disorders, which were more prevalent in the non-COVID-19 group (P value = 0.040), and inhaler use, which was higher in the COVID-19 group (P value = 0.027). Additionally, there was no significant difference between the COVID-19 group and the non-COVID-19 group in the number of patients who were admitted to the hospital ward during the interview. Moreover, the incidence of PTSD, anxiety, depression, cognitive deficit, and tics was significantly higher in the COVID-19 group than in the non-COVID-19 group. The COVID-19 group had a significantly lower mean EQ-VAS score than the non-COVID-19 group (P value = 0.000). On the other hand, the mean EQ-5D-5L assessment, mMRC scale and BCSS scores were significantly higher in the COVID-19 group than in the non-COVID-19 group. The detailed characteristics of the COVID-19 and non-COVID-19 cohorts are described in Table 1.
In the multivariate regression analysis, COVID-19 infection was significantly associated with PTSD, anxiety, depression, cognitive deficit, tics, EQ-VAS score, EQ-5D-5L assessment score, and BCSS score. In contrast, COVID-19 infection was not significantly associated with mMRC scale score. The COVID-19 survivor group had a significantly higher prevalence of PTSD than the non-COVID-19 survivor group (OR = 3.99; 95% CI 2.08–7.64). Similarly, a significantly higher prevalence of anxiety (OR = 2.40; 95% CI 1.41–4.45) and depression (OR = 4.11; 95% CI 2.25–7.48) was demonstrated in the COVID-19 survivor group than in the non-COVID-19 survivor group. Moreover, COVID-19 infection was associated with a higher prevalence of tics (OR = 4.90; 95% CI 2.16–11.12) and cognitive deficit (OR = 3.61; 95% CI 2.00–6.28). In addition, the COVID-19 survivor group had a significantly higher EQ-5D-5L assessment score (B = 1.81; 95% CI 1.10–2.92) and BCSS score (B = 0.56; 95% CI 0.15–0.97) than the non-COVID-19 survivor group. However, COVID-19 infection was significantly associated with a lower EQ-VAS score (B = − 8.31; 95%; 95% CI − 12.26 to − 4.52) (Table 2).
After stratification of COVID-19 survivors into groups based on the duration between infection and the time of the interview, each stratum of duration between COVID-19 infection and the interview was compared to that in the non-COVID-19 group for the occurrence of the outcome measures. The results showed that the odds of PTSD were significantly higher in the 6–12 month group (OR = 4.02; 95% CI 1.33–12.15) and the > 12 month group (OR = 5.17; 95% CI 1.91–14.00) than in the non-COVID-19 cohort. Similarly, the odds of anxiety were significantly higher in the 6–12 month group (OR = 4.41; 95% CI 1.66–11.64) and the > 12 month group (OR = 2.19; 95% CI 1.04–4.63) than in the non-COVID-19 cohort. However, the odds of both anxiety and PTSD were not significantly different between the < 6 month group and the non-COVID-19 cohort. On the other hand, depression was significantly higher in the < 6 month group (OR = 2.87; 95% CI 1.11–7.41), 6–12 month group (OR = 5.65; 95% CI 1.90–16.87) and > 12 month group (OR = 4.43; 95% CI 1.94–10.15) than in the non-COVID-19 cohort. Comparably, cognitive deficits were significantly higher in the < 6 month group (OR = 3.43; 95% CI 1.30–9.00), 6–12 month group (OR = 5.25; 95% CI 1.88–14.70) and > 12 month group (OR = 2.92; 95% CI 1.37–6.25) than in the non-COVID-19 cohort. Additionally, the odds of developing tics were significantly higher in the < 6 month group (OR = 5.35; 95% CI 1.59–17.75), 6–12 month group (OR = 8.43; 95% CI 2.42–29.32) and > 12 month group (OR = 3.41; 95% CI 1.20–9.72) than in the non-COVID-19 cohort. The mean EQ-5D-5L assessment score was significantly higher in the 6–12 month group (B = 2.09; 95% CI 0.67–3.70) and > 12 month group (B = 1.72; 95% CI 0.64–3.09) than in the non-COVID-19 cohort, while the score was not significantly different between the < 6 month group and the non-COVID-19 cohort. Moreover, the mean EQ-VAS score was significantly higher in the < 6 month group (B = − 7.24; 95% CI − 13.99 to − 0.50) and > 12 month group (B = − 11.28; 95% CI − 16.53 to − 6.02) than in the non-COVID-19 cohort, whereas the 6–12 month group was not significantly different in terms of EQ-VAS score compared to the non-COVID-19 cohort. On the other hand, the mean BCSS score was significantly higher in the < 6 month group than in the non-COVID-19 group (B = 1.02; 95% CI 0.32–1.71). However, this difference was not significant in the 6–12 month or the > 12 month groups compared to the non-COVID-19 cohort. There was no significant difference in the mMRC scale scores between any of the infection duration categories and the non-COVID-19 group (Table 3).
In the comparison according to vaccination status for the odds of developing PACS outcomes in the COVID-19 survivor cohort, only cognitive deficit and EQ-5D-5L assessment scores were significantly different between the vaccinated and nonvaccinated groups. The cognitive deficit prevalence (OR = 0.15; 95% CI 0.03–0.87) and the EQ-5D-5L assessment scores (B = − 2.11; 95% CI − 4.21 to − 0.20) were significantly lower in the vaccinated group than in the nonvaccinated group (Table 4).
To our knowledge, this is the first cohort study that evaluated PACS symptoms according to the time of COVID-19 infection. This study is also the first to evaluate tics as one of the components of PACS and the effect of COVID-19 vaccination on PACS symptoms.
According to our results, a higher prevalence of PTSD, anxiety, depression, cognitive deficit and tics was reported among COVID-19 survivors than among non-COVID-19 controls. COVID-19 survivors had a prevalence of PTSD, anxiety and depression of 84%, 38.4% and 75.2%, respectively, with a lower prevalence noted among non-COVID-19 controls of 59.7%, 19.3% and 45.5%, respectively. Similarly, studies reported that after COVID-19 infection, patients experienced high levels of anxiety, depression, and PTSD, with a prevalence of approximately 22%27. Although our study showed higher levels of PTSD, anxiety and depression among COVID-19 survivors, we also reported notable levels of the aforementioned conditions among non-COVID-19 controls, indicating that the pandemic had an impact on the general population regardless of their history of COVID-19 infection. This can be explained by the considerable mental health sequelae of the COVID-19 pandemic restrictions on COVID-19 patients as well as on people who were never infected28. In concordance with our findings, studies showed that cognitive deficit, including memory loss and concentration difficulties, was experienced by COVID-19 survivors29. These cognitive symptoms were associated with the presence of hypometabolic clusters in the brains of patients with PACS, as demonstrated using fluorodeoxyglucose (FDG)-positron emission tomography (PET)30. In addition, a recent case report described a patient that presented with a movement disorder after COVID-19 infection14. Previous studies showed a surge in tics and tic-like attacks during the COVID-19 pandemic, suggesting that this surge was due to the stress induced by the pandemic16. However, our study is the first to show that these tic-like attacks occurred at a higher frequency among COVID-19 survivors. Moreover, our results revealed that COVID-19 survivors had significantly lower EQ-5D-5L assessment and EQ-VAS scores, which indicates a lower quality of life and general health status. Additionally, our study revealed that COVID-19 survivors had higher BCSS scores, indicating a higher incidence of respiratory symptoms. However, mMRC scale scores were not significantly higher among COVID-19 survivors. Since the BCSS evaluates respiratory symptoms in a more comprehensive way than the mMRC scale by including sputum and cough, our results indicate that respiratory symptoms of PACS are not only driven by dyspnea but also by cough and sputum and are hence better assessed by the BCSS. Similar to our results, Zhang et al. illustrated that respiratory symptoms are common among COVID-19 survivors31.
Our analysis models demonstrated that COVID-19 survivors experienced a higher prevalence of depression, cognitive deficit, tics and respiratory symptoms during the first 6 months after the onset of infection. Likewise, impaired general health status was also prevalent during the first 6 months after infection. On the other hand, impaired quality of life, PTSD and anxiety were not significantly more prevalent among COVID-19 survivors until more than 6 months had elapsed from the onset of the infection. All these findings except for respiratory symptoms were prevalent 6–12 months and 12 months after the onset of infection. Comparable to our findings, studies showed that PACS symptoms persisted for up to 12 months after the onset of infection32. Additionally, it was shown that in more than 90% of patients, the time to recover from symptoms exceeded 9 months from the onset of infection33. Furthermore, a study on COVID-19 support groups demonstrated that after 6 months of follow-up, PACS symptoms persisted in a large proportion of patients34. However, it is important to mention that in our study, the peak in these symptoms (highest OR/B) was in the 6–12 month period, indicating that these symptoms increased from the onset of infection until 12 months, after which the prevalence decreased. The lower prevalence of PACS symptoms 12 months after the infection could be attributed to the fact that with time, the immune dysregulation status and the high cytokine levels described among PACS patients start to resolve, which was also described by Huang et al.31. Similarly, a study showed that the prevalence of PACS among the study patients increased from 27.8% at 4 months after the infection to 34.8% at 7 months34. Other studies showed that approximately half of the patients with PACS did not have any symptoms in the first 3 months after infection12. The neuropsychiatric symptoms were prevalent for much longer than respiratory symptoms, which can be explained by several hypotheses. One of these includes the bidirectional overlapping relationship between cognitive and psychiatric symptoms35, as it is well known that psychiatric symptoms, including stress, anxiety and depression, which persist due to the continued social and economic sequelae of the pandemic, might affect cognitive function36,37. Additionally, the pathophysiology of neuropsychiatric symptoms was attributed to the ability of the virus to penetrate and infect brain cells35. However, the relationship between the immune system and the brain is different from other organs in the body, as the brain has fewer immune cells and lymphatic systems, which might result in a delay in completely clearing the infection compared to organs highly enriched with lymphatics, such as the respiratory system38. Furthermore, to the best of our knowledge, this is the first study to report a reduction in symptoms 12 months after the onset of infection. Our results suggest that the absence of respiratory symptoms during clinical evaluation does not rule out the possibility of the development of neuropsychiatric symptoms. Additionally, the changes in symptom prevalence according to the time of infection demonstrated by our study might impact how clinicians address these symptoms. If PACS symptoms during the first 6 months after the onset of infection are absent, the patient must be screened for these symptoms 6–12 months after the infection, as the highest prevalence of these symptoms occurs in the period between 6 and 12 months after infection.
Although the pathogenesis of PACS is still not well understood, several hypotheses explaining this syndrome have been generated by observational studies39. Several studies showed that postvaccination breakthrough infections were associated with a reduction in the risk of the development of PACS symptoms40,41,42. However, our study is the first to report a reduction in the cognitive symptoms of PACS and quality of life impairment after COVID-19 vaccination. Symptoms other than those associated with cognitive function and quality of life impairment did not improve after vaccination. This finding can be explained by the fact that cognitive deficit was the only factor evaluated using an objective test (MoCA), as other symptoms were assessed using subjective tools. The reduction in PACS symptoms after COVID-19 vaccination can be explained by the formation of antibodies that can eliminate the persistent SARS-CoV-2 infection that was detected in a large number of PACS patients15.
This study had several strengths. Despite the fact that several studies have been conducted to explore PACS, few studies have focused on nonhospitalized patients. In addition, this is one of few studies to evaluate the changes in PACS symptom prevalence with time and to assess the newly reported symptoms of PACS, i.e., tics. Additionally, the use of comprehensive tools that were shown to be reliable in assessing PACS symptoms by Johns Hopkins Hospital is another strength. However, our study had several limitations. First, the moderate response rate, which resulted in a small sample size, could have introduced bias to the results of this study. This low response rate can be explained by the long interview that had to be conducted and the stigma surrounding mental health, as several of our outcomes were related to mental health. In addition, the lower number of COVID-19 survivors could be because the percentage of patients who were infected with COVID-19 comprises only 16% of the Jordanian population. Second, this was a single-center study, which limits the generalizability of our findings. Third, we did not have the baseline status of our outcome measures for COVID-19 survivors. Fourth, the retrospective design of this study can only predict association but not causality between the variables of the study. However, the retrospective design by its nature allows for long follow-up after the onset of COVID-19 infection. Although our models were adjusted for several confounders, the risk of confounding bias cannot be fully excluded. Furthermore, the ascertainment of COVID-19 survivors and noninfected cohorts was based on RT‒PCR testing. Since not all patients within the control group underwent RT‒PCR testing or serological tests, it was possible that some patients who were included in our noninfected cohort were previously infected with COVID-19, especially those with an asymptomatic infection who were less likely to be tested. However, the COVID-19 surveillance programs in Jordan included daily random testing, including asymptomatic patients, which might reduce the risk of ascertainment bias in our study. Including patients admitted to the hospital ward during the interview, which was after COVID-19 infection recovery, along with outpatients in our cohort is another limitation, as hospitalization during the interview time might result in several symptoms similar to PACS symptoms, and a subgroup analysis according to hospitalization status during the interview was not possible due to the small sample size. The reason behind including hospitalized patients was because they are more likely to tolerate long interviews compared to visitors of outpatient clinics. However, our results showed that there was no significant difference in the patients who were admitted to the hospital ward during the interview between the COVID-19 and control cohorts; hence, this is less likely to affect our results. Finally, we did not have any data about COVID-19 severity among COVID-19 survivors.
In conclusion, more than 1 year after the onset of COVID-19 infection, nonhospitalized COVID-19 survivors are still suffering from a higher prevalence of PTSD, anxiety, depression, cognitive deficit, and tics as well as lower quality of life and general health status than non-COVID-19 controls. However, it is important to mention that most of the symptoms reached their highest prevalence in the 6–12 month period and declined after the 12 month period. In addition, the respiratory symptoms were not different between the two study groups 6 months after the infection. Moreover, COVID-19 vaccination was shown to significantly decrease the prevalence of cognitive deficit and quality of life impairment among COVID-19 survivors. Longitudinal studies with long follow-up periods are needed to establish the time that should elapse after COVID-19 infection for the symptoms of PACS to subside and to better characterize the nature of PACS with a focus on tics. Additionally, randomized controlled clinical trials are needed to assess the possibility that COVID-19 vaccines might relieve PACS symptoms.
The data related to this article are available from the corresponding author upon reasonable request.
CDC. COVID-19 Symptoms. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html (2021). Accessed 1 Dec 2021.
Dergaa, I. et al. Age and clinical signs as predictors of COVID-19 symptoms and cycle threshold value. Libyan J. Med. 17, 2010337. https://doi.org/10.1080/19932820.2021.2010337 (2022).
CAS Article PubMed Google Scholar
Giangreco, G. Case fatality rate analysis of Italian COVID-19 outbreak. J. Med. Virol. 92, 919–923. https://doi.org/10.1002/jmv.25894 (2020).
CAS Article PubMed PubMed Central Google Scholar
Marois, G., Muttarak, R. & Scherbov, S. Assessing the potential impact of COVID-19 on life expectancy. PLoS ONE 15, e0238678. https://doi.org/10.1371/journal.pone.0238678 (2020).
CAS Article PubMed PubMed Central Google Scholar
Andrasfay, T. & Goldman, N. Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations. 118, e2014746118 https://doi.org/10.1073/pnas.2014746118. (2021).
Chippa, V., Aleem, A. & Anjum, F. in StatPearls (StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC., 2021).
Varma, A. et al. COVID-19 and diabetes in primary care—How do hematological parameters present in this cohort?. Expert. Rev. Endocrinol. Metab. 16, 147–153. https://doi.org/10.1080/17446651.2021.1909472 (2021).
CAS Article PubMed Google Scholar
Xiong, Q. et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 27, 89–95. https://doi.org/10.1016/j.cmi.2020.09.023 (2021).
CAS Article PubMed Google Scholar
Yong, S. J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 53, 737–754. https://doi.org/10.1080/23744235.2021.1924397 (2021).
CAS Article Google Scholar
Peghin, M. et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 27, 1507–1513. https://doi.org/10.1016/j.cmi.2021.05.033 (2021).
CAS Article PubMed PubMed Central Google Scholar
Cirulli, E. T. et al. Long-term COVID-19 symptoms in a large unselected population. https://doi.org/10.1101/2020.10.07.20208702 (2020).
Taquet, M. et al. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 18, e1003773. https://doi.org/10.1371/journal.pmed.1003773 (2021).
CAS Article PubMed PubMed Central Google Scholar
Chen, C. et al. Global prevalence of post-acute sequelae of COVID-19 (PASC) or long COVID: A meta-analysis and systematic review. https://doi.org/10.1101/2021.11.15.21266377 (2021).
Garg, A., Goyal, S. & Comellas, A. P. Post-acute COVID-19 functional movement disorder. SAGE Open Med. Case Rep. https://doi.org/10.1177/2050313×211039377 (2021).
Article PubMed PubMed Central Google Scholar
Massey, D. et al. Change in Symptoms and immune response in people with post-acute sequelae of SARS-Cov-2 infection (PASC) after SARS-Cov-2 vaccination. https://doi.org/10.1101/2021.07.21.21260391 (2021).
Heyman, I., Liang, H. & Hedderly, T. COVID-19 related increase in childhood tics and tic-like attacks. 106, 420–421. https://doi.org/10.1136/archdischild-2021-321748 (2021).
Hosey, M. M. et al. Screening for posttraumatic stress disorder in ARDS survivors: Validation of the Impact of Event Scale-6 (IES-6). Crit. Care 23, 276. https://doi.org/10.1186/s13054-019-2553-z (2019).
Article PubMed PubMed Central Google Scholar
McCarroll, M. L., Pohle-Krauza, R. J., Volsko, T. A., Martin, J. L. & Krauza, M. L. Use of the breathlessness, cough, and sputum scale (BCSS(©)) in pulmonary rehabilitation. Open Respir. Med. J. 7, 1–5. https://doi.org/10.2174/1874306401307010001 (2013).
Article PubMed PubMed Central Google Scholar
Rahman, T. T. A. & El Gaafary, M. M. Montreal cognitive assessment Arabic version: Reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. 9, 54–61. https://doi.org/10.1111/j.1447-0594.2008.00509.x (2009).
Spitzer, R. L., Kroenke, K., Williams, J. B. W. & Löwe, B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch. Intern. Med. 166, 1092–1097. https://doi.org/10.1001/archinte.166.10.1092 (2006).
Article PubMed Google Scholar
Urtasun, M. et al. Validation and calibration of the patient health questionnaire (PHQ-9) in Argentina. BMC Psychiatry 19, 291. https://doi.org/10.1186/s12888-019-2262-9 (2019).
Article PubMed PubMed Central Google Scholar
Williams, N. The MRC breathlessness scale. Occup. Med. 67, 496–497. https://doi.org/10.1093/occmed/kqx086 (2017).
Article Google Scholar
Herdman, M. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20, 1727–1736. https://doi.org/10.1007/s11136-011-9903-x (2011).
CAS Article PubMed PubMed Central Google Scholar
Brigham, E. et al. The Johns Hopkins Post-Acute COVID-19 Team (PACT): A multidisciplinary, collaborative, ambulatory framework supporting COVID-19 survivors. Am. J. Med. 134, 462-467.e461. https://doi.org/10.1016/j.amjmed.2020.12.009 (2021).
CAS Article PubMed PubMed Central Google Scholar
EuroQol Research Foundation. EQ-5D-5L User Guide, 2019. https://euroqol.org/publications/user-guides. Accessed 1 Jan 2022.
Feise, R. J. Do multiple outcome measures require p-value adjustment?. BMC Med. Res. Methodol. 2, 8. https://doi.org/10.1186/1471-2288-2-8 (2002).
Article PubMed PubMed Central Google Scholar
Khraisat, B., Toubasi, A., AlZoubi, L., Al-Sayegh, T. & Mansour, A. Meta-analysis of prevalence: The psychological sequelae among COVID-19 survivors. Int. J. Psychiatry Clin. Practice. https://doi.org/10.1080/13651501.2021.1993924 (2021).
Article Google Scholar
Wang, C. et al. The impact of the COVID-19 pandemic on physical and mental health in the two largest economies in the world: A comparison between the United States and China. J. Behav. Med. 44, 741–759. https://doi.org/10.1007/s10865-021-00237-7 (2021).
Article PubMed PubMed Central Google Scholar
Lopez-Leon, S. et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Res. Square. https://doi.org/10.21203/rs.3.rs-266574/v1 (2021).
Article Google Scholar
Guedj, E. et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging 48, 2823–2833. https://doi.org/10.1007/s00259-021-05215-4 (2021).
CAS Article PubMed PubMed Central Google Scholar
Zhang, X. et al. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw. Open 4, e2127403. https://doi.org/10.1001/jamanetworkopen.2021.27403 (2021).
Article PubMed PubMed Central Google Scholar
Huang, L. et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet 398, 747–758. https://doi.org/10.1016/S0140-6736(21)01755-4 (2021).
CAS Article PubMed PubMed Central Google Scholar
Vaes, A. W. et al. Recovery from COVID-19: A sprint or marathon? 6-Month follow-up data from online long COVID-19 support group members. ERJ Open Res. https://doi.org/10.1183/23120541.00141-2021 (2021).
Article PubMed PubMed Central Google Scholar
Augustin, M. et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Regional Health Europe. https://doi.org/10.1016/j.lanepe.2021.100122 (2021).
Article PubMed PubMed Central Google Scholar
Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27, 601–615. https://doi.org/10.1038/s41591-021-01283-z (2021).
CAS Article PubMed PubMed Central Google Scholar
Shields, G. S., Sazma, M. A., McCullough, A. M. & Yonelinas, A. P. The effects of acute stress on episodic memory: A meta-analysis and integrative review. Psychol. Bull. 143, 636–675. https://doi.org/10.1037/bul0000100 (2017).
Article PubMed PubMed Central Google Scholar
Akbari, H. A. et al. How physical activity behavior affected well-being, anxiety and sleep quality during COVID-19 restrictions in Iran. Eur. Rev. Med. Pharmacol. Sci. 25, 7847–7857. https://doi.org/10.26355/eurrev_202112_27632 (2021).
CAS Article PubMed Google Scholar
Alves de Lima, K., Rustenhoven, J. & Kipnis, J. Meningeal immunity and its function in maintenance of the central nervous system in health and disease. Annu. Rev. Immunol. 38, 597–620. https://doi.org/10.1146/annurev-immunol-102319-103410 (2020).
CAS Article PubMed Google Scholar
Maltezou, H. C., Pavli, A. & Tsakris, A. Post-COVID syndrome: An insight on its pathogenesis. Vaccines. https://doi.org/10.3390/vaccines9050497 (2021).
Article PubMed PubMed Central Google Scholar
Antonelli, M. et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Diseases. https://doi.org/10.1016/S1473-3099(21)00460-6 (2022).
Article Google Scholar
Taquet, M., Dercon, Q. & Harrison, P. J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. https://doi.org/10.1101/2021.10.26.21265508 (2021).
Massey, D., Berrent, D. & Krumholz, H. Breakthrough symptomatic COVID-19 infections leading to long COVID: Report from long COVID facebook group poll. https://doi.org/10.1101/2021.07.23.21261030 (2021).
Download references
The authors thank Miss Sara Zaqut for her linguistic assistance.
These authors contributed equally: Asma S. Albtoosh and Ahmad A. Toubasi.
Department of Respiratory and Sleep Medicine, Department of Internal Medicine, School of Medicine, The University of Jordan, Amman, Jordan
Asma S. Albtoosh & Khaled Al Oweidat
Faculty of Medicine, The University of Jordan, Amman, 11942, Jordan
Ahmad A. Toubasi, Manar M. Hasuneh, Abdullah H. Alshurafa & Daniah L. Alfaqheri
Department of Internal Medicine, School of Medicine, The University of Jordan, Amman, Jordan
Randa I. Farah
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
A.A.T. and A.S.A. were involved in the conceptualization of this study; A.A.T., A.S.A., M.M.H., A.H.A., D.L.A., K.A. and R.I.F. were involved in data curation, formal analysis, investigation, methodology, project administration, resources, software, validation, visualization, and writing the original draft; A.S.A., K.A. and R.I.F. were involved in supervision and reviewing and editing the manuscript.
Correspondence to Ahmad A. Toubasi.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Reprints and Permissions
Albtoosh, A.S., Toubasi, A.A., Al Oweidat, K. et al. New symptoms and prevalence of postacute COVID-19 syndrome among nonhospitalized COVID-19 survivors. Sci Rep 12, 16921 (2022). https://doi.org/10.1038/s41598-022-21289-y
Download citation
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-21289-y
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
Advertisement
© 2022 Springer Nature Limited
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b–2, open-label study – The Lancet
If you don’t remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Please enter a term before submitting your search.
Access provided by
Usmani S, Berdeja J, Madduri D, et al. EP964: Updated CARTITUDE-1 results of ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T cell therapy. Replased/refractory multiple myeloma. European Hematology Association; June 4–17, 2021 (abstr EP964).
DOI: https://doi.org/10.1016/S2352-3026(22)00284-8
We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.
Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


